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ABSTRACT 
James Paul Shellhammer: Coordination of G Protein and Mitogen-Activated Protein Kinase 
Signaling Pathways by Branched-Chain Amino Acid Metabolite Second Messengers during 
Osmotic Stress 
(Under the direction of Henrik G. Dohlman) 
Cells experience a variety of environmental signals, often simultaneously. These signals 
may encode opposing effects, so the response must be coordinated in a manner that promotes cell 
and organismal well-being. The expression of surface receptors, such as G protein-coupled 
receptors (GPCRs), aids in the detection of bioactive molecules. Once perceived by the cell, the 
signal is transduced to intracellular signaling components that carry out the appropriate response. 
Mitogen-activated protein kinase (MAPK) cascades are commonly activated in response to 
external stimuli that range from growth factors to environmental stresses. The budding yeast S. 
cerevisiae employs MAPK pathways to respond to mating pheromones and environmental 
stresses. The pheromone response pathway is a MAPK pathway regulated by a GPCR, and the 
high osmolarity glycerol (HOG) pathway is a parallel MAPK pathway that shares some 
components with the pheromone response pathway. Signal fidelity is maintained during 
simultaneous activation of these and other MAPK pathways through mechanisms including 
signal strength and duration, feedback regulation, and cross-pathway inhibition. In this 
dissertation, I identify a new means by which parallel MAPK pathways are regulated. I show that 
activation of the HOG pathway promotes the production of second messenger molecules derived 
from branched-chain amino acids. These new second messengers promote phosphorylation of the 
Gα subunit regulating the pheromone response pathway, and lead to reduced downstream 
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transcriptional output. I also compare conventional and recently developed methods for 
analyzing MAPK activation and gene transcription.  This work adds to our understanding of how 
signaling pathway cross-talk can maintain signal fidelity, and provides an update on the methods 
that can be used to best study these pathways for future discoveries.  
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To all first-generation graduate students, be proud of what you have done, and have faith in 
what you can achieve. 
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CHAPTER 1 – INTRODUCTION 
The environment in which a cell exists is ever changing. To survive, the cell must be able 
to take in information about its environment, process this information, and execute a response 
that permits adaptation to the changes. This is true throughout all of life, but here the focus is on 
eukaryotic systems. Eukaryotes have evolved sophisticated cellular signaling systems that are 
used to relay information about the surroundings of the cell to the inside of the cell, where 
adaptive changes are executed. Among the most studied molecules responsible for detecting 
extracellular signals are G protein-coupled receptors (GPCRs). These cell membrane proteins 
serve crucial functions in maintaining homeostasis, and regulate critical processes including 
heart rate, blood pressure, and neurotransmission. As such, GPCRs are molecular targets for 
drugs that regulate these and other processes. 
In addition to maintaining homeostasis, cells must respond to signals that promote cell 
growth and proliferation, as well as signals that are detrimental to the well-being of the cell or 
organism. For these processes, cells employ an extremely well-conserved intracellular signaling 
module called the mitogen-activated protein kinase (MAPK) cascade. MAPKs are 
serine/threonine kinases that are activated in response to extracellular cues, such as growth 
factors, hormones, and cytokines that promote cell growth, proliferation, or motility. MAPKs are 
also activated in response to cell stressors, such as ultraviolet irradiation, oxidative stress, and 
osmotic stress, and serve to increase production of proteins that can help the cell to overcome the 
stressful environment [1].  
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These are but two examples of many types of signaling pathways that exist in eukaryotic 
cells, and even within GPCR and MAPK pathways there are several classes of each protein, and 
MAPKs are activated downstream of a variety of receptor types, including GPCRs [2]. At any 
given time, the extracellular environment may contain hundreds of potential ligands for 
membrane receptors, in addition to any physical stimuli that can exert a cellular response. As 
such, many signaling cascades are active simultaneously, and some components of these 
cascades are shared among other pathways. In order to properly process the information that is 
presented to a cell, it must have mechanisms in place to maintain signaling fidelity. Cell-type-
specific expression of proteins and compartmentalization of molecules help to greatly reduce the 
potential for aberrant signaling. Crosstalk between signaling pathways is another mechanism by 
which cells maintain signaling fidelity [3]. In this work, I identify a new means by which one 
MAPK pathway can regulate a parallel MAPK pathway by promoting the production of new 
second messenger molecules that regulate upstream G protein signaling. This work adds to a 
growing body of work from the Dohlman lab that serves to highlight the importance of signaling 
pathway crosstalk in maintaining signal fidelity in the face of a complex environment [4, 5]. 
  
Heterotrimeric G Protein Signaling 
The most prominent class of druggable molecules is comprised of G protein-coupled 
receptors (GPCRs). Currently, an estimated 30% of all prescription drugs target members of the 
GPCR family [6]. These receptors are seven-transmembrane-spanning molecules that serve to 
transmit an extracellular cue, such as light [7], smell [8] or taste [9], or the presence of hormones 
or neurotransmitters, to the inside of the cell, where an appropriate physiological response can 
then be executed [10]. 
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The first step in executing the response to an activated GPCR is the activation of the 
associated heterotrimeric G protein. G proteins are so-named for their ability to bind guanine 
nucleotides. The specific guanine nucleotide that is bound to the G protein dictates its state of 
activity. A G protein bound to guanosine diphosphate (GDP) is inactive, whereas a G protein 
bound to guanosine triphosphate (GTP) is considered to be active. In addition to its ability to 
bind to guanine nucleotides, a G protein also possesses the ability to hydrolyze the gamma 
phosphate on GTP to yield GDP.  In this way, G proteins act as molecular switches that cycle 
between the “on” and “off” states. While G proteins can intrinsically convert from the “on” state 
to the “off” state, and subsequently release GDP and bind a new GTP molecule, the rates for 
these processes are very slow [11]. Cells have evolved the ability to use the switch-like 
properties of G proteins to control when particular effector molecules are activated. This is 
achieved by accelerating the rates of GDP exchange and GTP hydrolysis in a four-stage G 
protein signaling cycle (Figure 1.1), beginning with an inactive, GDP-bound G protein.  
The role of the GPCR is to act as guanine nucleotide exchange factor (GEF) to facilitate 
the exchange of GDP for GTP, and thereby turn the switch to the “on” position. Upon agonist 
binding, the GPCR undergoes a conformational change that is transmitted through the entire 
protein to alter the three-dimensional structure of the intracellular domain. This altered structure 
is preferred for association with the heterotrimeric G protein, and subsequent nucleotide 
exchange. A G protein heterotrimer consists of the Gα subunit, which possesses the guanine 
nucleotide binding and hydrolytic functions, and the obligate heterodimer, Gβγ. The Gα subunit 
is composed of two domains—the Ras-like domain (so-called because of its structural similarity 
to the small GTPase, Ras), and the α-helical domain [12-14]. Upon GTP binding to Gα, 
conformational changes in three “switch regions” in the Ras-like domain promote dissociation of  
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Figure 1.1  Heterotrimeric G protein activation cycle. 
i.) In the absence of a GPCR-activating ligand, the G protein is in the inactive, GDP-bound state, 
with all three subunits (Gα and Gβγ) in complex. ii.) Upon agonist binding, the GPCR acts as a 
guanine nucleotide exchange factor for the Gα subunit, promoting exchange of GDP for GTP 
and dissociation of Gβγ from Gα. iii.) Activated, GTP-bound Gα and dissociated Gβγ are free to 
interact with downstream effectors to transmit the GPCR-activating signal. iv.) Regulator of G 
protein signaling proteins interact with Gα, and act as GTPase accelerating proteins to by 
stabilizing the transition state (GDP-P) of nucleotide hydrolysis. Hydrolysis of GTP to GDP 
returns Gα to the inactive state, promoting re-association with Gβγ and termination of the signal.   
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Gβγ from Gα. Both dissociated subunits can then go on to bind effector molecules in the next 
step of G protein signal transduction.  Signaling events following activation of the G protein 
serve to regulate the duration for which the G protein remains in the “on” state. One way that G 
protein signaling is terminated is through interaction with members of the Regulator of G protein 
Signaling (RGS) family of proteins.  RGS proteins act as GTPase accelerating proteins (GAPs) 
to increase the rate of GTP hydrolysis [15] by stabilizing the hydrolytic transition state, and thus 
serve to turn the switch to the “off” position [16]. The re-formation of a GDP-bound Gα and 
reassociation with Gβγ completes the cycle of G protein activation. 
 In addition to this canonical scheme, G proteins can be regulated through 
phosphorylation and other post-translational modifications, including myristoylation [17], 
palmitoylation [18], and ubiquitination [19, 20]. The lipid modifications serve to localize G 
proteins to the plasma membrane, and therefore promote closer proximity to the GPCRs that 
activate them. The role of Gα phosphorylation is more complex, and less understood. 
The work in this dissertation is primarily focused on phosphorylation of the yeast Gα 
subunit, Gpa1. As the goal for conducting research in model organisms, such as yeast, is to be 
able to translate those findings to the human system, here I will briefly introduce what is known 
about phosphorylation of mammalian G proteins, and details on Gpa1 phosphorylation will be 
covered in the next chapter. Several Gα family members have been identified as being modified 
by phosphorylation. The kinases responsible for these phosphorylation events were identified as 
protein kinase A (PKA) [21, 22], protein kinase C (PKC) [23], calcium/calmodulin-dependent 
protein kinase (CaMK) [24], and Src [25]. The consequences of phosphorylation vary and 
include reduced affinity for guanine nucleotides [22], inhibition of interaction with Gβγ [23], 
reduced binding with RGS proteins [26], and inhibition of interaction with downstream effectors 
 6 
 
[21]. However, conclusive consequences of Gα phosphorylation on overall signaling in 
mammals are still poorly understood. 
 
Second Messenger Signaling 
There are 16 mammalian Gα subunits, and they can be divided into four classes based on 
the main effector molecules with which they interact [27]. These sub-type based classes are Gαs, 
Gαi, Gαq, and Gα12/13. The first three of these four classes work to control second messenger 
production, while the fourth is involved in cell polarity (Figure 1.2) [27, 28]. The concept of 
second messenger signaling originates from work by Earl Sutherland in 1957 [29] when he 
discovered that liver phosphorylase was stimulated indirectly by hormones, requiring a “heat-
stable factor” that was later identified as cyclic adenosine monophosphate (cAMP) [30]. Second 
messenger signaling is now recognized as an entire paradigm of cell signaling. In this paradigm, 
signaling is initiated by a first messenger (e.g., hormone or neurotransmitter) that activates a cell 
surface receptor (canonically a GPCR). Activation of the receptor leads to activation of 
intracellular effector molecules (e.g., adenylate cyclase) that produce the second messenger 
molecule (e.g., cAMP). The production of second messengers greatly amplifies the original 
signal, promoting a rapid and robust intracellular response [31]. Over the years, many additional 
second messengers have been identified. These include cGMP [32], inositol trisphosphate (IP3) 
[33, 34], diacylglycerol (DAG) [35], and calcium [36]. The work in this dissertation presents a 
new class of second messengers produced not by G protein signaling, but through activation of 
the stress-response mitogen-activated protein kinase (MAPK) pathway. I find that these second 
messengers promote phosphorylation of the yeast Gα, Gpa1, and serve to regulate a parallel 
MAPK pathway that is controlled by the G protein.  
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Figure 1.2  G protein signaling through effectors specific to Gα subclasses. 
Gαs, Gαi, and Gαq subclasses regulate second messenger production, while Gα12/13 has roles in 
cytoskeletal rearrangement and cell motility. From left, Gαs family proteins increase cAMP 
through activation of adenylate cyclase (AC). Gαi family proteins decrease cAMP through 
inhibition of AC. Gαq family proteins increase IP3 and DAG through activation of 
phospoholipase C (PLC). Gα12/13 family members promote cell motility through small GTPases, 
such as RhoA. Gβγ subunits have signaling effects including activation of PI3 kinase and 
indirect activation of MAPK pathways.  
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Mitogen-Activated Protein Kinase Signaling 
Mitogen-activated protein kinases (MAPKs) are a class of cytoplasmic enzymes that are 
activated by various extracellular signaling cues, ranging from mitogens (as the name suggests), 
growth factors, cytokines and signals activating GPCRs, to environmental stress stimuli. MAPKs 
are the terminal component of a three-tiered kinase cascade module consisting of the MAP 
kinase kinase kinase (MAPKKK), the MAP kinase kinase (MAPKK) and the MAPK, as well as 
a scaffolding protein to bring the three kinase components together. The MAPK module has been 
highly conserved throughout evolution among all eukaryotes, emphasizing the efficiency of such 
a protein complex in signal transduction.  The MAPK is activated via phosphorylation by the 
MAPKK on conserved tyrosine and threonine residues. In turn, the activated MAPK recognizes 
and phosphorylates the serine or threonine in a specific PX(S/T)P motif on protein substrates in 
the cytoplasm and nucleus to regulate functions such as cell proliferation and adaptation to 
stressful or damaging stimuli. Deactivation of MAPKs is regulated by dephosphorylation by 
specific MAPK phosphatases [1]. 
Humans possess four major MAPK pathways—the extracellular signal-regulated kinase 
(ERK)1/2 pathway, the p38 MAPK pathway, the c-Jun N-terminal kinase (JNK) pathway, and 
the ERK5 pathway [1]. The ERK1/2 pathway is activated by a range of growth factors and 
cytokines, and is involved in cell growth and proliferation. The p38 MAPK and JNK pathways, 
also called stress-activated protein kinases (SAPKs), are activated in response to environmental 
stressors, such as oxidative stress, ultraviolet irradiation, osmotic stress, and heat shock, as well 
as inflammatory cytokines [1]. ERK5, like ERK1/2, responds to growth factors and carries out 
many similar functions in cell-cycle regulation, but also has specific roles in cardiovascular 
development, angiogenesis, and neuronal differentiation [37]. 
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The modular design of MAPK pathways helps to increase the versatility of MAPK 
systems, but also increases the potential for aberrant signaling. Despite only four main pathways, 
there exist at least 20 MAPKKKs, 7 MAPKKs, and 11 MAPKs. Thus, different MAPK modules 
can be assembled in response to different activating signals to achieve different functions, 
including transcription, proliferation, cell motility, cell death, and development [38]. In order to 
maintain signal fidelity, cells have developed multiple regulatory mechanisms. Part of this 
regulation is achieved through cell-type-specific expression of the different isoforms. Regulation 
in cells expressing the same isoforms is achieved through multiple mechanisms, localization, 
docking domain specificity, signal duration and intensity, and feedback phosphorylation by 
activated MAPKs [3, 4]. In this work, I identify another means by which MAPK signaling 
specificity can be regulated through pathway crosstalk; production of second messenger 
molecules is initiated by one MAPK pathway to control the activity of a parallel MAPK 
pathway. 
 
Osmotic Stress adaptation 
The response to different physical or chemical stresses is mediated by MAPK pathways 
networks. For example, ultraviolet irradiation and oxidative damage, inflammatory cytokines, 
and osmotic shock promote signaling through activation of the p38 and JNK MAPK pathways 
[39-41]. While much progress has been made in understanding the intracellular response to 
conditions such as oxidative stress and ultraviolet radiation damage, the processes involved in 
osmotic stress are often overlooked in relation to human health.  
Osmotic stress occurs when the solute concentration (osmolarity) in the extracellular 
space deviates from the osmolarity of the intracellular space. A higher osmolarity in the 
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extracellular space relative to the intracellular space is considered a hyperosmotic stress, and a 
lower osmolarity in the extracellular space relative to the intracellular space is a hypo-osmotic 
stress. Hereafter, osmotic stress will refer to hyperosmotic stress. Upon encountering osmotic 
stress, cells rapidly lose water through osmosis in order to normalize the osmotic balance 
between the intracellular and extracellular space. The loss of intracellular water results in cell 
shrinkage. In cases of severe osmotic stress, this cell shrinkage can lead to macromolecular 
crowding and, thus, a hampered ability for biochemical processes to occur [42]. Under less-
severe osmotic stress, cells initiate signaling events that promote reactive oxygen species (ROS) 
production, DNA damage, cell cycle arrest, and apoptosis [43].  
In addition to these negative effects, cells also initiate signaling events that promote 
adaptation to osmotic stress by activating p38 MAPK. Upon activation, p38 MAPK 
phosphorylates the transcription factor NFAT5, which promotes the transcription of 
osmoprotective target genes. These include genes associated with the synthesis and transport of 
osmolytes, antioxidants, and molecular chaperones [44-46].  
Several tissues routinely experience osmotic stress, and can develop disease if 
osmoregulation is impaired. For example, osmotic stress in ocular tissue can promote dry eye 
disease [47] and diabetic retinopathy [48], and high osmolarity in the vasculature can lead to 
hyperosmolar hyperglycemic state in diabetics [49], and various cardiovascular complications 
caused by hypertension and changes in erythrocyte deformability [50, 51]. The pathways used to 
activate the cellular response to osmotic stress appear to be, in some ways, cell type specific 
[51], emphasizing the need for a more complete understanding of the osmotic stress response to 
aid in developing treatment strategies for associated pathologies.  
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Yeast as a Model Organism to Study Cell Signaling 
Studying the mechanisms of pathway cross-talk and coordination is often challenging due 
to the expression of multiple protein isoforms, and differences in the expression of these 
isoforms among various cell types and tissues. Researchers often seek ways to simplify the 
complex human system by using model organisms that retain many of the desired features for 
study, but offer a more manageable number of components. This allows us to gain a basic 
understanding of how a given system works that can be built upon by moving into higher, more 
complex systems of study. The budding yeast, Saccharomyces cerevisiae, has been one of 
Nature’s greatest gifts to mankind. In addition to its uses for hundreds of years in baking and 
brewing, yeast offer scientists the ability to study signaling pathways and processes in the 
simplest of eukaryotic systems.  
Yeast exists stably in both diploid and haploid states. Using haploid cells affords a high 
degree of genetic tractability, making studies involving gene deletion or point mutation much 
easier than in a diploid system. Strain libraries are available that contain strains harboring 
individual deletion of each non-essential gene [52] and inducible knock-down of essential genes 
[53], as well as epitope-tagged versions of each protein with TAP [54] or GST [55] for 
purification or identification by immunoblotting, and GFP [56] for determining cellular 
localization or expression levels by microscopy or flow cytometry. Yeast also grow and 
reproduce quickly, with a cell division cycle that lasts roughly two hours, reducing the time scale 
necessary for completing experiments. Finally, and perhaps most importantly, yeast possess 
well-characterized signaling pathways whose component proteins have been highly conserved 
throughout evolution. Two such pathways are the G protein signaling and MAPK pathways [57, 
58]. In contrast to mammals, which possess ~800 GPCRs, 16 Gα subunits, and 11 MAPKs, yeast 
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possess 3 GPCRs, 2 Gα subunits, and 5 MAPKs, thus greatly simplifying the task of 
understanding how these pathways operate and coordinate. Two yeast MAPK pathways are most 
similar to mammalian MAPK pathways. The yeast pheromone response pathway is highly 
homologous to the mammalian ERK1/2 pathway in its roles in cell growth and proliferation, and 
the yeast high osmolarity glycerol pathway is homologous to the p38 MAPK pathway in its role 
in responding to environmental stress. These pathways are described below. 
 
The Yeast Pheromone Response Pathway: A Model for G Protein and MAPK Signaling 
Yeast exist in two haploid mating types: a-type and α-type. To form a diploid a/α cell, the 
two haploid types must mate. Much like higher eukaryotic organisms, yeast use pheromones to 
attract a mate. The a-type cells secrete a peptide pheromone called a-factor, and α-type cells 
secrete a pheromone called α-factor. These pheromones act as chemotropic agents; upon sensing 
the pheromone from the opposite mating type, cells will form a mating projection, or “shmoo”, 
toward the source of the pheromone gradient (a.k.a. a mating partner), until the two cells 
ultimately fuse to form a diploid cell. Mating pheromones also act to arrest the cell cycle in the 
G1 stage, and to promote transcription of genes necessary for the mating response and cell 
fusion. The signaling pathway responsible for sensing and carrying out the mating response, 
called the pheromone response pathway, is a canonical GPCR signaling pathway that regulates a 
prototypical MAPK cascade (Figure 1.3) [59]. 
The pheromone response pathway is activated upon binding of mating pheromone to a 
GPCR (Ste2 in a-cells, Ste3 in α-cells) [60]. As described above, GPCRs act as GEFs for 
heterotrimeric G proteins, promoting the exchange of GDP for GTP in the Gα subunit (Gpa1) 
and subsequent dissociation of Gβγ (Ste4/Ste18). Once dissociated from Gpa1, Ste4/Ste18  
 13 
 
 
 
Figure 1.3  The yeast pheromone response pathway. 
Yeast detect mating pheromone from opposite mating types by a GPCR. Here, the GPCR Ste2 
expressed on an a-type cell detects α-factor secreted by an α-type cell. Exchange of GTP for 
GDP in the Gpa1(Gα) promotes dissociation of Ste4/Ste18 (Gβγ). Free Gβγ recruits the MAPK 
scaffold protein Ste5 and the PAK Ste20 (membrane-localized by Cdc42) into complex. The 
MAPKKK Ste11 is recruited to Ste5, and then brought into activation proximity to Ste20 by the 
adapter protein Ste50. The MAPKK Ste7 and MAPK Fus3 are recruited to Ste5. Activation of 
Ste11 by Ste20 promotes activation of Ste7, and subsequently, Fus3. The MAPK Kss1 is 
activated by Ste7, but does not require scaffolding. Activated Fus3 and Kss1 translocate to the 
nucleus, where they phosphorylate the transcription factor Ste12, promoting transcription of 
pheromone response elements (PREs). Kinases in the MAPK module are shown in light green.  
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recruits and binds to the MAPK scaffolding protein Ste5, and the p21-activated kinase Ste20. 
The adapter protein Ste50 is associated with Ste20, and serves to recruit the MAPKKK, Ste11 to 
the scaffold, where upon activation by Ste20, Ste11 activates the MAPKK, Ste7. Subsequently, 
the MAPK, Fus3 is activated upon binding with Ste5 [57, 61]. A second MAPK, Kss1 is also 
activated by Ste7, but does not require scaffolding by Ste5 [62]. Once activated, Fus3 and Kss1 
translocate to the nucleus and phosphorylate the pathway-specific transcription factor Ste12, 
which then promotes transcription of genes required for cell mating (Figure 1.3) [63, 64]. 
 
The High Osmolarity Glycerol Pathway: A Model for Stress Response Signaling 
Yeast use a MAPK pathway parallel to the pheromone response pathway to respond to 
osmotic stress. The High Osmolarity Glycerol, or HOG, pathway is activated upon increases in 
extracellular osmolarity [65]. Unlike the pheromone response pathway, the HOG pathway can be 
activated by two distinct branches that later converge on the MAPKK, Pbs2 (Figure 1.4). In 
addition to its role as MAPKK, Pbs2 serves as the scaffold protein for the HOG MAPK module 
[66]. The MAPK, Hog1 is the yeast ortholog of mammalian p38 MAPK [58]. 
The first branch of the HOG pathway is the Sho1 branch. Increased extracellular 
osmolarity is detected by two osmosensor proteins, Hkr1 and Msb2 [67]. The signal is then 
transmitted to the inside of the cell by another transmembrane protein, Sho1. The detailed 
mechanism by which this is achieved is unknown. However, Sho1 and an associated membrane 
protein Opy2 appear to have important functions in scaffolding the p21-activated kinase, Ste20 
and the activated small G protein Cdc42. These two proteins are also employed in the pheromone 
response pathway, and similarly, recruit the MAPKKK Ste11 and the adapter protein Ste50 to 
the cell membrane. Sho1 also serves as a scaffold for the MAPKK, Pbs2. Hog1 is then recruited  
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Figure 1.4  The yeast High Osmolarity Glycerol (HOG) pathway. 
The response to hyperosmotic stress is mediated by a MAPK pathway with two upstream input 
branches that converge on the MAPKK, the Sln1 branch (left shaded) and the Sho1 branch (right 
shaded). The Sln1 branch uses a histidine kinase/receiver protein (Sln1) and phospho-relay 
system through Ypd1 and Ssk1 to maintain pathway deactivation. Hyperosmotic stress disrupts 
Sln1 histidine kinase activity and releases inhibiting phosphorylation on Ssk1, promoting 
activation of the MAPKKKs Ssk2/22. The Sho1 branch uses mucin-related proteins Hkr1 and 
Msb2 to sense hyperosmotic stress. The signal is transmitted across the cell membrane by Sho1 
and Opy2, which recruit Active Cdc42 and associated Ste20 to the membrane. As with the 
pheromone response pathway, Ste20 activates the MAPKKK Ste11. MAPKKK activation by 
either branch results in activation of the scaffold/MAPKK Pbs2, and subsequent activation of the 
MAPK Hog1. Active Hog1 translocates to the nucleus to phosphorylate transcription factors, 
promoting transcription of stress response elements (SREs). Hog1 also phosphorylates 
cytoplasmic proteins to promote stress adaptation.   
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to and activated by Pbs2 (Figure 1.4) [65].  
The second branch of the HOG pathway is the Sln1 branch. A loss in turgor pressure 
associated with increased extracellular osmolarity is sensed by the  histidine kinase/receiver 
protein, Sln1, that is similar to the two-component systems in prokaryotes [68]. Sln1, Ypd1, and 
Ssk1 form a phospho-relay system that is active during normal conditions. Phosphorylation of 
Ssk1 is inhibitory to its catalytic function. Upon sensing osmotic stress, The Sln1 two-
component system is disrupted, and the phospho-relay is deactivated. Ssk1 inhibition is relieved, 
and Ssk1 phosphorylates the redundant MAPKKKs Ssk2/Ssk22 [65]. These MAPKKKs then 
activate the MAPKK, Pbs2, which phosphorylates and activates Hog1. Upon activation, Hog1 
phosphorylates cytoplasmic and nuclear proteins to aid in the restoration of osmotic equilibrium 
through synthesis of osmolytes, such as glycerol and trehalose, export of ions, and stress 
response gene transcription (Figure 1.4) [69]. 
 
Metabolomics 
 In the on-going search for a more-complete understanding of how physiological systems 
function and how these systems develop disease, “-omics” technologies have come to take the 
foreground. Omics approaches allow the functional monitoring of many cellular pathways 
simultaneously. Systems biology methods have been developed to conduct global analyses of 
each component of the central dogma of biology—DNA (genomics), mRNA (transcriptomics), 
and protein (proteomics)—and extended one step further to examine the small-molecule products 
of enzymatic reactions, metabolites (metabolomics) [70]. One goal for these approaches is to be 
able to characterize the networks that regulate cell function in an unbiased and systematic 
description way. Once we truly understand how a cell functions on the global scale, we can 
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better develop treatments for when these networks are compromised. A long-term goal for these 
approaches then is to develop personalized medicine, where treatment is designed based on the 
specific disease state of an individual. While we still may be far from achieving this goal, -omics 
technologies have contributed to great leaps forward. 
Metabolomics presents the ability to examine a nearly complete complement of small 
molecules present in a given cell type through mass spectrometry- and NMR-based approaches. 
After extraction of metabolites from cell lysates, supernatants, body fluids, or tissues, samples 
can be analyzed by LC-MS/MS [71], GC-MS [72], and/or NMR [73]. The spectra are compared 
to a library of spectra of known metabolites, and the metabolome of the sample is identified. 
Metabolomes from different mutants and/or cells subjected to different treatment conditions can 
be compared to answer a variety of scientific questions. In this way, progress has been made in 
identifying biomarkers and metabolic signatures for diseases such as obesity [74], diabetes [75], 
heart failure [76], and differential effects of disease in hosts of altered microbiomes have been 
mapped [77-79]. Here, we use a metabolomics approach to identify 2-hydroxy branched-chain 
amino acid derivatives as second messengers of osmotic stress.  
 
Dissertation Summary 
The remaining sections of this dissertation are presented in three chapters. In Chapter 2, 
“Amino Acid Metabolites that Regulate G Protein Signaling during Osmotic Stress”, I present 
the identification of a new class of second messenger molecules derived from the three branched-
chain amino acids, valine, leucine, and isoleucine. I identified these second messengers by a 
comprehensive metabolomics screen, and found that they are produced in a manner dependent 
upon osmotic stress, and requiring the yeast stress-response MAPK, Hog1. Through functional 
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studies, I found that these second messengers are necessary and sufficient to promote the 
phosphorylation of the yeast Gα, Gpa1, and serve to diminish the output of the pheromone 
response MAPK pathway. Through this work, I propose that in addition to its canonical role as a 
regulator of second messenger production, the G protein can be regulated by second messengers 
produced through activation of the stress-responsive MAPK pathway in a new mechanism of 
pathway coordination. 
In Chapter 3, I present a methods update for studying MAPK pathways, focusing on 
phosphorylated MAPK western blotting and pathway-specific transcriptional reporter assays. I 
compare conventional immunoblot analysis using standard SDS-PAGE, followed by probing 
with phospho-specific antibodies, and the recently developed Phos-tag immunoblotting method, 
where individual phosphorylated species are separated in proportion to the number of 
phosphorylation sites. To analyze transcriptional output, I compare an enzyme-based β-
galactosidase assay and a fluorescent protein based GFP assay. These assays are compared in the 
yeast pheromone response pathway, but can be adapted for use in studying MAPK pathways in 
other organisms. 
Finally, in Chapter 4, “General Discussion and Conclusions”, I discuss the broader 
impacts of my dissertation research, offer future directions for this research, and speculate on the 
future directions of the field.  
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CHAPTER 2 – AMINO ACID METABOLITES THAT REGULATE G PROTEIN 
SIGNALING DURING OSMOTIC STRESS 
Summary 
All cells respond to osmotic stress by implementing molecular signaling events to protect 
the organism. Failure to properly adapt can lead to pathologies such as hypertension and 
ischemia-reperfusion injury. Many signaling nodes, including mitogen-activated protein kinases 
(MAPKs), are activated in response to osmotic stress and by signals acting through G protein-
coupled receptors (GPCRs). For proper adaptation, the action of these kinases must be 
coordinated. To identify second messengers of stress adaptation, we conducted mass 
spectrometry-based global metabolomics profiling analysis, quantifying nearly 300 metabolites 
in the yeast S. cerevisiae. We show that three branched-chain amino acid (BCAA) metabolites 
increase in response to osmotic stress and require the MAPK Hog1. Ectopic addition of BCAA 
derivatives promotes phosphorylation of the G protein α subunit and dampens G protein-
dependent transcription, similar to that seen in response to osmotic stress. Conversely, genetic 
ablation of Hog1 activity or the BCAA-regulatory enzymes leads to dampened phosphorylation 
of Gα and increased gene transcription. Taken together, our results define a new class of second 
messengers that regulate a novel cross-talk mechanism for adapting to osmotic stress. 
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Introduction 
Cells routinely experience changing and often unfavorable conditions in their 
environment. The ability to adapt to environmental stress and re-establish homeostasis is 
essential not only to the survival of a cell, but also to the well-being of the organism. The 
response to such physical or chemical stresses is mediated by well-defined signaling networks. 
For example, changes in nutrient availability switch signaling between the opposing mammalian 
target of rapamycin (mTOR) and AMP-activated protein kinase (AMPK) pathways [80, 81] and 
promote signaling through the ERK2 mitogen-activated protein kinase (MAPK) [82]. Stressors 
such as UV irradiation, inflammatory cytokines, and osmotic shock promote signaling through 
activation of the p38 and c-Jun N-terminal Kinase (JNK) MAPK pathways [39-41]. While much 
is known about the mechanisms of stress-dependent signaling, less is known about the 
mechanisms of cross-pathway signal coordination. In this study, we report the regulatory effects 
of signaling cross-talk between osmotic stress and G protein-coupled receptor (GPCR) signaling 
pathways. 
Hyperosmotic stress causes water efflux and cell shrinkage in order to normalize the 
osmotic balance between the intracellular and extracellular space. Depending on the severity of 
the stress, cell shrinkage can lead to macromolecular crowding and alterations in cellular protein 
activity [42], the production of reactive oxygen species (ROS), DNA damage, cell cycle arrest, 
and apoptosis [43]. In addition to these negative effects, cells also initiate signaling events that 
promote adaptation. Most prominently, in eukaryotes osmotic stress activates homologs of the 
stress response MAPK p38, which in turn phosphorylates myriad downstream targets that 
coordinate osmotic stress adaptations. This includes targets such as the transcription factor 
NFAT5, which promotes the transcription of osmoprotective target genes, including those 
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associated with the synthesis and transport of osmolytes, antioxidants, and molecular chaperones 
[44-46]. These changes ensure the survival of the cell, and they are likely to have important 
consequences for other signaling pathways via cross-talk mechanisms. 
Previously, we have shown that cross-talk between nutrient sensing and GPCR pathways 
causes phosphorylation of the Gα subunit [5], the principle transducer of GPCR signals. As the 
largest receptor family in humans [4], GPCRs respond to a wide variety of homeostatic cues, 
such as hormones and neurotransmitters, as well as to environmental signals such as odors and 
light through intracellular heterotrimeric G proteins, comprised of Gα and Gβγ subunits. G 
proteins in turn serve to transmit signals between activated GPCRs and downstream effectors. 
Activation of effector proteins promotes production of second messenger molecules such as 
calcium or cAMP, which bind to and activate intracellular protein kinases. Another mechanism 
of GPCR signaling entails the direct activation of protein kinases upstream of MAPKs [10].  
The Gα subunit is a molecular on/off switch for signaling processes. As such, it is likely to be a 
critical target for post-translational modifications that regulate GPCR signaling, whether by 
intra-pathway mechanisms or by cross-talk with other pathways. In fact, several studies have 
shown that Gα proteins are phosphorylated, resulting in altered affinity for Gβγ subunits or 
guanine nucleotides [21-25, 83]. In some cases, phosphorylation is the direct result of pathway 
activation, and thus constitutes a positive or negative feedback. In other cases, phosphorylation is 
triggered by parallel pathways and thus constitutes a mechanism of signal coordination or cross-
talk. Our focus here is cross-talk regulation of G protein and osmotic stress response MAPK 
pathways.   
Identifying how environmental stress can promote post-translational modification of Gα 
subunits is necessary to fully understand the mechanisms by which the pathways are coordinated 
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and integrated. Studying the response to environmental stress is often challenging, however, due 
to the expression of multiple protein isoforms and differences in expression among various 
tissues and cell types. Given these complexities, much can be learned from the analysis of 
orthologous signaling processes in simpler eukaryotes.  
The budding yeast Saccharomyces cerevisiae has a stress response pathway and a GPCR 
signaling pathway with component proteins that are evolutionarily conserved across eukaryotes 
[57, 58]. The High Osmolarity Glycerol, or HOG, pathway is comprised of a MAPK (Hog1), a 
MAPK kinase (Pbs2), and MAPK kinase kinases (Ste11, Ssk2/Ssk22). Upon activation, Hog1 
phosphorylates cytoplasmic and nuclear proteins to aid in the restoration of osmotic equilibrium 
through osmolyte synthesis and the induction of stress response genes [69]. Hog1 is the yeast 
ortholog of mammalian p38. 
Yeast use another, parallel MAPK pathway to initiate haploid cell fusion, or mating. This 
pathway is activated by pheromone binding to a GPCR to initiate exchange of GDP for GTP in 
the Gα subunit (Gpa1) and subsequent dissociation of Gβγ. Gβγ activates a MAPKKK (Ste11, 
shared by the HOG pathway), a MAPKK (Ste7) and a MAPK (Fus3). Once activated, Fus3 
promotes transcription of genes to initiate cell mating [57]. Fus3 is the yeast ortholog of 
mammalian ERK1 and ERK2. 
In the present study, we use yeast as a model system to investigate how crosstalk 
regulates G protein signaling in response to environmental stress. We have shown previously that 
osmotic stress dampens the pheromone response pathway, but the mechanism has not been 
explored [4]. We have also shown that glucose limitation dampens the pheromone response 
pathway, and does so by reducing intracellular pH [84]. The increase in proton concentration is 
detected by the G protein directly, resulting in increased phosphorylation of Gpa1. Additionally, 
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we have identified a family of three kinases (Elm1, Sak1, and Tos3) and a PP1 phosphatase 
complex (Reg1/Glc7) as the molecular machinery responsible for phosphorylating and 
dephosphorylating Gpa1 [5]. We show here that Gpa1 is likewise phosphorylated in response to 
osmotic stress, and that phosphorylation of Gpa1 requires the same protein kinases, but does not 
entail any changes in intracellular pH. In an unbiased metabolomics screen, we determine that 2-
hydroxy branched chain amino acid metabolites are produced in a salt- and Hog1-dependent 
manner. Finally, we show that these metabolites are necessary and sufficient to promote Gpa1 
phosphorylation and dampen downstream signaling. We propose that these metabolites represent 
a new class of second messengers of the stress-responsive HOG pathway. 
 
Results 
Gpa1 is phosphorylated in response to environmental stress 
To understand how cells adapt to environmental stresses, we sought to identify conditions 
that impact pheromone signaling through the phosphorylation of Gpa1. We recently established 
that Gpa1 is phosphorylated by a family of three AMPK kinases (Elm1, Sak1, and Tos3), and 
dephosphorylated by the phosphatase complex Reg1/Glc7 [5]. These proteins were previously 
shown to phosphorylate and dephosphorylate the yeast AMPK, Snf1 [85-87]. Snf1, is 
phosphorylated and activated in response to nutrient limitation, as well as heat shock, 
hyperosmotic shock, reactive oxygen species, ethanol, and changes in extracellular pH [88]. 
Accordingly, we asked whether the same environmental stressors would lead to phosphorylation 
of Gpa1. We treated wild-type cells with the indicated stressor in a 2-hour time-course (see 
Materials and Methods), and cell lysates were analyzed by western blot. As shown in Figure 2.1, 
Gpa1 and Snf1 were phosphorylated in all stress conditions tested (see also Figure 2.2). 
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However, among the stressors there were differences in the both the magnitude and duration of 
phosphorylation. In glucose-limiting conditions, approximately 90% of Gpa1 was 
phosphorylated by 2 minutes, with a gradual decline after 10 minutes (Figure 2.1A). Heat shock 
(30 minutes at 42°C) also promoted rapid phosphorylation but slow dephosphorylation. Osmotic 
stress promoted slow phosphorylation, but fast dephosphorylation. Heat and osmotic stress also 
promoted the phosphorylation of Snf1, but the effects were comparatively weak and transient 
(Figure 2.1B, C) [88]. These data reveal that Gpa1, like Snf1, is phosphorylated in response to 
various stress signals. More broadly, the results indicate that physico-chemically distinct stimuli 
have a common ability to promote phosphorylation of two functionally distinct proteins, Snf1 
and Gpa1. 
It is well-established that the MAPK Hog1 is phosphorylated and activated in response to 
osmotic stress. Hog1 is also activated by heat shock [89], cold stress [90], oxidative stress [91], 
and hypoxia [92]. Given that many of these conditions also lead to phosphorylation of Gpa1 and 
Snf1, we asked if Hog1 activation was required in either case. To this end, we replaced Hog1 
with a mutant that lacks catalytic activity, hog1
K52R
 [93], and treated the cells with 0.5 M KCl. 
Whereas Snf1 phosphorylation was unperturbed, the phosphorylation of Gpa1 was almost 
completely abrogated in the hog1
K52R
 strain (compare Figure2.1C, blue curve vs. red curve). 
These data indicate that osmotic stress-induced phosphorylation of Gpa1, but not Snf1, is 
dependent upon Hog1 catalytic activity. More broadly, these results implicate at least two 
distinct signaling pathways, and potentially two distinct second messengers, that mediate the 
response to osmotic stress.  
One potential second messenger is pH. Indeed, it is well established that glucose 
limitation leads to a substantial decrease in intracellular pH (pHi). We have shown recently that  
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Figure 2.1  Phosphorylation of Gpa1 in response to osmotic stress occurs in a Hog1-
dependent, pH-independent manner. 
Western blot analysis reveals that Gpa1 and Snf1 are phosphorylated (p-Gpa1 and p-Snf1) in 
response to (A) glucose (Glc) limitation (“High” = 2% glucose, “Low” = 0.05% glucose), (B) 
heat shock (42 °C, 30 minutes), or (C) osmotic stress (0.5 M KCl). Note that Hog1 is 
phosphorylated (p-Hog1) in response to heat shock or osmotic stress, but not glucose limitation. 
Intracellular pH (insets) decreases in response to glucose limitation or heat shock, but not 
osmotic stress. Hog1 catalytic activity (hog1
K52R
) is required for phosphorylation of Gpa1 but not 
Snf1. Diploid, control cells lacking Gpa1. reg1Δ, control cells lacking Gpa1 phosphatase. Hog1, 
Snf1, and Load correspond to gels probed with Hog1, Snf1 and G6PDH antibodies, respectively. 
Data presented as mean ± standard deviation, N = 3.  
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Figure 2.2  Additional stress conditions promote Gpa1 phosphorylation with differing 
effects on intracellular pH. 
In addition to salt, heat and glucose stress, Gpa1 is phosphorylated in response to (A) non-ionic 
osmotic stress, (B) oxidative stress, (C) ethanol stress, and (D) alkaline pH. (A-D, insets) Intra-
cellular pH decreases in response to oxidative- and ethanol stress, but not non-ionic osmotic 
stress, and increases in response to alkaline pH. Data presented as mean ± standard deviation, 
N = 3. 
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Gpa1 is a pH sensor, and that pH-dependent changes in conformation result in phosphorylation 
of the protein [84]. Since other stressors trigger phosphorylation of Gpa1, we asked whether any 
of those conditions also cause a change in pHi. To that end we expressed the ratiometric 
fluorescent pH biosensor, pHluorin, in wild-type cells [84, 94, 95]. Consistent with earlier 
studies [84], we observed a decrease in pHi from 7.0 to 6.4 upon glucose limitation (Figure 2.1A, 
inset). In contrast, cells subjected to osmotic stress exhibited no change in pHi over the course of 
60 minutes (Figure 2.1C and Figure 2.2). These data indicate that low glucose and osmotic stress 
each promote Gpa1 phosphorylation, but glucose alone affects pHi. We therefore postulated the 
existence of an additional second messenger of the osmotic stress response. 
Global metabolomics analysis of second messengers for osmotic stress 
The data presented above reveal that osmotic stress has no effect on pHi, yet is a potent 
inducer of Gpa1 phosphorylation. To identify potential second messengers of osmotic stress, we 
conducted a global, unbiased metabolomics analysis [75, 96]. Based on results from the Gpa1 
phosphorylation experiments above, we sought to identify metabolites that increased with 
osmotic stress and in a Hog1-dependent manner. To this end, we subjected wild-type and Hog1-
deficient yeast cells to 0.5 M KCl for 20 minutes and then analyzed cell extracts by LC-MS/MS 
and GC-MS (Figure 2.3A). This analysis identified 296 distinct entities representing each major 
class of biochemical molecules– amino acids, peptides, carbohydrates, lipids, nucleic acids, 
vitamins and cofactors, and xenobiotics. Consistent with past findings, we found that the 
osmolytes trehalose [97] and glycerol [98] were induced substantially (32-fold and 2.5-fold, 
respectively) (Figure 2.3C, Table 2.1). Using a comparable (2-fold) cut off, we identified an 
additional 26 metabolites that increased in response to osmotic stress, and 13 that increased in 
the presence of Hog1. Of these, only three required osmotic stress and Hog1 together  
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Figure 2.3  Global metabolomics analysis identifies candidate second messengers for 
osmotic stress.  
(A) Metabolites from wild-type and hog1Δ cells, untreated or treated for 20 minutes with 0.5 M 
KCl, were extracted and analyzed by GC-MS and LC-MS/MS. (B) 296 unique metabolites were 
identified. Venn diagram of metabolites that increase >2-fold in response to osmotic stress 
(n=28), in cells that express Hog1 (n=13) or both (n=3). (C) Heat map of metabolites that 
increase in salt-treated wild-type compared to unstressed wild-type cells (left column, top), and 
increase in salt-treated wildtype, but not salt-treated hog1Δ cells(right column, bottom). Colored 
arrows indicate 2-hydroxy carboxylic acid derivatives of the BCAAs valine (HIV, green), 
leucine (HIC, red), and isoleucine (HMVA, blue). (D, Top) Relative abundance of the three 
BCAA derivatives and (D, Bottom) their parent amino acids. Data presented as mean ± standard 
deviation, N = 5. 
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Table 2.1  Metabolite fold-change values for Figure 2.3 heatmap. 
Metabolite Fold change with osmotic 
stress in wild-type vs. 
untreated wild-type 
Fold change with 
osmotic stress in wild-
type vs. hog1Δ 
trehalose 32.28 1.96 
guanosine 5'- monophosphate (5'-GMP) 13.27 2.27 
cytidine 5'-monophosphate (5'-CMP) 8.38 1.61 
2-hydroxyisocaproate (2-HIC) 4.95 3.85 
adenosine 5'-monophosphate (AMP) 4.24 1.20 
adenosine 3.75 0.85 
2-hydroxyisovalerate (2-HIV) 3.45 2.70 
3-hydroxykynurenine 3.23 0.78 
phenyllactate (PLA) 3.21 1.96 
2-hydroxy-3-methylvalerate (2-H3MP) 3.16 2.94 
dimethylarginine (SDMA + ADMA) 3.05 1.32 
putrescine 2.85 1.45 
1-oleoylglycerophosphoserine 2.8 0.88 
glucosamine 2.63 1.41 
nicotinamide riboside* 2.59 1.75 
glycerol 2.51 1.47 
3-(4-hydroxyphenyl)lactate 2.5 1.52 
acetyl CoA 2.42 1.35 
2-oleoylglycerophosphoserine* 2.26 0.81 
tyrosol 2.23 1.49 
threonylleucine 2.2 1.39 
cadaverine 2.17 1.11 
erythronate* 2.16 1.96 
N-acetylhistidine 2.15 1.22 
glycerophosphoethanolamine 2.11 1.04 
glycerol 2-phosphate 2.07 1.32 
spermidine 2.06 1.39 
guanine 2.05 1.20 
2-hydroxyisocaproate (2-HIC) 4.95 3.85 
malate 0.53 3.85 
argininosuccinate 1.54 2.94 
2-hydroxy-3-methylvalerate (2-H3MP) 3.16 2.94 
GDP-mannose 0.62 2.78 
2-hydroxyisovalerate (2-HIV) 3.45 2.70 
2-hydroxyglutarate 1.58 2.38 
5-methylthioadenosine (MTA) 1.57 2.33 
citrate 0.5 2.33 
cis-aconitate 1.84 2.33 
methionine 0.95 2.08 
erythritol 1.44 2.04 
adenine 1.76 2.00 
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(Figure 2.3B, C): 2-hydroxyisovalerate (HIV), 2-hydroxyisocaproate (HIC), and 2-hydroxy-3-
methylvalerate (HMVA). All three compounds are 2-hydroxy carboxylic acid derivatives of the 
branched-chain amino acids (BCAAs) valine, leucine, and isoleucine, respectively (Figure 2.3C, 
D). Thus, our analysis points to 2-hydroxy BCAA derivatives as candidate second messengers of 
osmotic stress. 
Branched-chain aminotransferase null mutants exhibit reduced stress-induced 
phosphorylation of Gpa1 
Our metabolomics study demonstrated that BCAA derivatives are produced in response 
to osmotic stress, and that their production requires Hog1 (Figure 2.3D). In principle, deleting 
Hog1 could alter the production of additional second messengers that may not have been 
detected in our metabolomics screen. However, as BCAA derivatives were the most robustly 
increased metabolites that met our criteria for osmotic stress, we examined the consequences of 
disrupting BCAA catabolism through the so-called Ehrlich pathway in yeast [99]. The first step 
in the pathway is transamination to an α-keto acid by the branched-chain amino acid 
transaminases, Bat1 and Bat2 (Figure 2.4A). The resulting α-keto acid is subsequently reduced to 
the 2-hydroxy acid (Figure 2.4A). Products of the Ehrlich pathway are exported from the cell by 
the ABC transporter Pdr12 [99, 100].  
To test whether BCAA derivatives are required for phosphorylation of Gpa1 and/or Snf1, 
we deleted the BAT1 and BAT2 genes individually (Figure 2.4B). After osmotic stress, we 
observed a modest, but significant reduction in maximal phosphorylation of Gpa1 in the bat1Δ 
and bat2Δ mutants, as compared to wild-type cells (Figure 2.4B, C). As expected, Snf1 
phosphorylation was maintained in the bat1Δ mutant (Figure 2.4B). Cells harboring deletion of 
both BAT genes are reported to be viable [101, 102]; however in our hands, bat1Δbat2Δ double  
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Figure 2.4  BCAA derivatives are necessary for a full response to osmotic stress.  
(A) BCAAs are converted to α-keto acids by the BCAA transaminases, Bat1 and Bat2. The α-
keto acids are subsequently reduced to the 2-hydroxy acids, and ultimately exported by the fusel 
acid transporter, Pdr12. (B, C) Genetic ablation of BAT1 or BAT2, or (B, E) loss of MAPK 
phosphorylation consensus sites (Bat1
5A
 Bat2
3A
) leads to reduced Gpa1 phosphorylation. (B, D) 
Genetic ablation of PDR12 does not affect Gpa1. Data presented as mean ± standard deviation, * 
indicates p ≤ 0.05, N = 3.  
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mutants arose at a lower-than-predicted frequency after tetrad dissection and likely harbored 
suppressor mutations. As an alternative approach, we attempted to use a tetracycline-repressible 
BAT1 in a bat2Δ background. However, the doxycycline used to repress BAT1 expression also 
promoted the phosphorylation of Gpa1. Gpa1 phosphorylation was unaffected by loss of the 
transporter gene PDR12 (Figure 2.4D). Together these results indicate that either Bat1 or Bat2 is 
necessary for cell viability. Both proteins, as well as their catalytic products, are necessary for a 
full response to osmotic stress. 
MAPK-dependent phosphorylation of branched-chain amino acid transaminases does not 
affect Gpa1 phosphorylation after osmotic stress 
 Our results indicate that Hog1 activity and BCAA catabolism are both needed for a full 
response to osmotic stress. In particular, we have shown that osmotic stress-dependent Gpa1 
phosphorylation is reduced in mutants lacking Bat1 or Bat2, and is eliminated in cells lacking 
Hog1 catalytic activity. Based on these findings, we hypothesized that Hog1 phosphorylates one 
or more components of the Ehrlich pathway. Indeed, Bat1 possesses five MAPK consensus sites 
(S/TP), and Bat2 possesses three such sites. In support of our hypothesis, replacement of the 
MAPK consensus sites led to a significant reduction in Gpa1 phosphorylation (Figure 2.4B, E). 
However, there were no changes in the electrophoretic (phosphorylation-dependent) mobility of 
Bat1, Bat2, Bat1
5A
, or Bat2
3A
, either in the absence or presence of salt stress. There was also no 
effect of osmotic stress on Bat2
3A
 in cells lacking Bat1 (bat1Δ Bat23A) or Bat15A in the absence 
of Bat2 (Bat1
5A
 bat2Δ) (Figure 2.5). Taken together, these results suggest that Hog1 does not 
target the transaminases, and instead plays an indirect role in promoting the production of BCAA 
derivatives. 
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Figure 2.5  Bat1 and Bat2 phosphorylation and abundance are unaffected by osmotic 
stress. 
Phos-tag western blots of (A) Bat1-Flag and Bat1
5A
-Flag or (B) Bat2-Flag and Bat2
3A
-Flag 
reveal no detectable changes in phosphorylation after osmotic stress. (C) Western blot analysis of 
(C) Bat1-Flag or (D) Bat2-Flag reveals no change in abundance after osmotic stress. Putative 
non-phosphorylated (Bat1, Bat2), mono-phosphorylated (p-Bat1, p-Bat2) and dual 
phosphorylated (pp-Bat1, pp-Bat2) species are indicated. WT, untagged control. Data presented 
as mean ± standard deviation, N = 3. 
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Ectopic addition of BCAA derivatives promotes Gpa1 phosphorylation in the absence of 
osmotic stress 
An intracellular second messenger should, by definition, be sufficient as well as 
necessary to evoke the response of the extracellular first messenger. Having demonstrated that 
BCAA derivatives are necessary for a full response to osmotic stress, we tested the ability of the 
BCAA derivatives to promote phosphorylation in the absence of the stimulus. To better enable 
these compounds to traverse the cell membrane, we grew the cells at pH 5, which is closer to the 
pKa of the metabolites. By favoring the protonated, uncharged species, the BCAA derivatives can 
more easily traverse the plasma membrane. Importantly, the lower external pH does not change 
the intracellular pH [84]. Using this approach, we found that HIV, HIC, and HMVA promoted 
Gpa1 phosphorylation, but with varying efficacy. HIC showed the strongest effect while HIV 
had the weakest effect (Figure 2.6). Hog1 was not activated by BCAA derivatives, consistent 
with the idea that their production is a consequence of Hog1 activation. Snf1 was likewise 
unaffected, consistent with the idea that it is regulated by a distinct second messenger. Taken 
together, these experiments indicate that BCAA derivatives are sufficient to promote 
phosphorylation of Gpa1 and thus meet the criteria for second messengers of osmotic stress. 
BCAA derivatives do not bind directly to Gα proteins 
Our results so far show that BCAA derivatives promote the phosphorylation of Gpa1. We 
next attempted to delineate the mechanism by which BCAA derivatives act. Our lab has 
demonstrated previously that protons directly interact with the G protein α subunit, causing a 
conformational change that promotes its phosphorylation. Moreover, the pH dependent change is 
conserved in yeast and human Gα proteins [84]. We hypothesized that BCAA derivatives might 
likewise act by binding to the Gα subunit. To test the potential mechanism, we employed NMR  
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Figure 2.6  BCAA derivatives promote Gpa1 phosphorylation in the absence of osmotic 
stress. 
(A) Ectopic addition of HIC promotes phosphorylation of Gpa1 but not  Hog1 or Snf1. (B) 
Ectopic addition of the BCAA derivatives promote Gpa1 phosphorylation while intracellular pH 
is unaffected (inset). Data presented as mean ± standard deviation, N = 3.  
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spectroscopy. 
1
H-
15
N 2D heteronuclear NMR spectra of 
15
N-enriched Gα were collected in the 
absence and presence of BCAA derivatives. These spectra allow for the detection of protons 
directly bonded to a 
15
N, including both backbone and side-chain NH resonances. As an NH 
resonance can be detected for every residue, with the exception of proline, the spectrum contains 
a “fingerprint” of the protein backbone and allows perturbations resulting from interactions to be 
detected on a per-residue basis. This approach is widely considered as a definitive method for 
detecting low- to intermediate-affinity binding of ligands to proteins [103]. Accordingly, we 
acquired the NMR spectra of Gαi in its GDP-bound state, alone or in the presence of a 25-fold 
excess of individual BCAA derivatives. As shown in Fig. 5, there were no significant peak shifts 
when BCAA derivatives were present (Figure 2.7A-C). As a positive control, we acquired NMR 
spectra of Gαi-GDP at pH 6 and at pH 7. As shown in Figure 2.7D, a substantial number of 
peaks are shifted at the lower pH, consistent with proton-dependent conformational changes in 
Gαi. These results indicate that BCAA derivatives likely target another component of the G 
protein signaling pathway. 
The AMPK kinase Elm1 phosphorylates Gpa1 in response to osmotic stress and BCAA 
derivative production 
Gpa1 is phosphorylated by the AMPK kinases Elm1, Sak1, and Tos3 [5]. Whereas Elm1 
phosphorylates Gpa1 in a cell-cycle-dependent manner [83], Sak1 is responsible for 
phosphorylation during glucose limitation [5]. Our data presented above indicate that Gpa1 is 
likewise phosphorylated in response to osmotic stress. To determine which, if any, of the AMPK 
kinases mediates the response to osmotic stress, we compared Gpa1 phosphorylation in cells 
lacking each of the three kinases, alone or in combination. As shown in Figure 2.9, deletion of 
ELM1 resulted in the greatest reduction of Gpa1 phosphorylation, while deletion of SAK1 had a  
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Figure 2.7  BCAA derivatives do not bind directly to G proteins.  
1
H-
15N 2D HSQC NMR spectra of Gαi-GDP alone (black) or in the presence of 25-fold excess 
(A) HIV, (B) HIC, or (C) HMVA (color) reveal no discernable peak shifts. (D) Spectral overlay 
of Gαi-GDP at pH 6.0 (magenta) and pH 7.0 (black) is presented as a positive control.  Inset, 
magnified view of a subset of resonances showing pH-dependent spectral changes.  
 42 
 
 
 
Figure 2.8  The AMPK kinase Elm1 phosphorylates Gpa1 upon BCAA derivative addition.  
Gpa1 phosphorylation after ectopic addition of 30 mM HIC is abrogated in cells lacking the 
AMPK kinase ELM1, or all three AMPK kinases (ΔΔΔ). Data presented as mean ± standard 
deviation, N = 3.  
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Figure 2.9  The AMPK kinase Elm1 phosphorylates Gpa1 upon osmotic stress or BCAA 
derivative addition. 
(A) Gpa1 phosphorylation after addition of 0.5 M KCl is diminished in cells lacking ELM1 and 
abrogated in cells lacking all three AMPK kinases (ΔΔΔ). In contrast to Gpa1, phosphorylation 
of Snf1 requires Sak1 but not Elm1. (B) Gpa1 phosphorylation after ectopic addition of 30 mM 
HIC is abrogated in cells lacking the AMPK kinases TOS3 and ELM1 or SAK1 and ELM1. Data 
presented as mean ± standard deviation, N = 3.  
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comparatively small effect. We then performed the same experiment using BCAA metabolites in 
place of osmotic stress. As with salt stimulation, HIC promoted the phosphorylation of Gpa1 in 
cells, and phosphorylation was diminished in the elm1Δ mutant (Figure 2.8 and Figure 2.9). 
Taken together, these results indicate that both the primary messenger (osmotic stress) and the 
putative second messenger (the BCAA derivatives) act through Elm1. More broadly, these 
results confirm a fundamental difference between glucose- and salt-dependent changes in the 
cell. While both conditions lead to Gpa1 phosphorylation, they lead to the production of two 
distinct second messengers (protons and BCAA derivatives) and to phosphorylation by two 
distinct protein kinases (Sak1 and Elm1). 
Osmotic stress and BCAA derivatives dampen the pheromone response MAPK pathway 
 We have shown that osmotic stress leads to a diminished pheromone response [4] and 
phosphorylation of the Gα protein (this work). Based on our model, the BCAA derivatives are 
responsible for many of the intracellular effects of osmotic stress signaling including Gα 
phosphorylation. According to our proposed mechanism, the same metabolites should also 
dampen the response to pheromone. To test this hypothesis, we employed a transcriptional 
reporter assay using GFP under control of the FUS1 promoter, which is specific to the 
pheromone response pathway [104]. We then measured fluorescence in response to increasing 
concentrations of the α-factor mating pheromone, alone or in combination with KCl or the 
BCAA derivatives. Consistent with previous reports [4], osmotic stress dampened the 
pheromone response by approximately 40%. Consistent with our present model, the addition of 
HIV, HIC, or HMVA also led to a diminished response of up to 40% (Figure 2.10A). The 
capacity of each BCAA derivative to dampen transcription correlated directly with its ability to 
promote Gpa1 phosphorylation (figure 2.6B). Deletion of the Gpa1 kinases confers an elevated 
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Figure 2.10  BCAA derivatives diminish MAPK-dependent gene transcription.  
(A) Addition of BCAA derivatives, or KCl, dampens α-factor pheromone-induced gene 
transcription (PFUS1-GFP). The dampening capacity of each BCAA derivative is correlated with 
Gpa1 phosphorylation (see Fig. 4). (B) Genetic ablation of the AMPK kinases increases basal 
gene transcription, consistent with reduced Gpa1 phosphorylation. Correspondingly, the kinase 
mutants abrogate any ability of the metabolites to suppress basal signaling and limit their ability 
to suppress pheromone signaling (41% reduction in wildtype vs. 26% reduction in the kinase 
mutant strain). Data are presented as mean ± standard deviation, N = 4.  
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signal at all but the highest concentrations of pheromone. At 10 uM pheromone the mutant strain 
was less sensitive to KCl and HIC (a reduction of 27% and 26%) compared to wild type (35 and 
41%, respectively). At low and intermediate concentrations, the mutant strain was less 
responsive to salt and largely unresponsive to the BCAA derivatives (Figure 2.10B). Thus, 
BCAA derivatives are produced in response to an osmotic stress stimulus and, by every measure 
used, appear to mimic the biochemical effects of the osmotic stress signal. By these criteria the 
BCAA derivatives function as second messengers of the osmotic stress response pathway.  
 
Discussion 
Here, we present several novel features of the pheromone response pathway that we 
believe will be generally applicable to other MAPK signaling systems. First, we show that 
multiple environmental stressors lead to G protein phosphorylation. Phosphorylation of Gpa1 is 
accompanied by attenuated signaling through the effector MAPK, Fus3 [4, 5, 84]. Second, we 
show that many of these same stressors trigger the activation of another MAPK, Hog1. When 
Hog1 is activated, Fus3 signaling is inactivated. Third, we present the results of a comprehensive 
screen of small molecule metabolites, and show that 2-hydroxy BCAA derivatives are generated 
in response to osmotic stress and Hog1 activation. We show further that these metabolites are 
sufficient to trigger Gpa1 phosphorylation and dampening of the Fus3 pathway. Finally, we 
show that the protein kinase Elm1 is responsible for phosphorylating Gpa1 in response to 
osmotic stress and by addition of the metabolites. While the target of these metabolites remains 
to be identified, we have largely excluded the kinase and G protein substrate as candidates. 
Based our findings, we propose that BCAA metabolites represent a newly described 
“second messenger” of stress-activated signaling. The concept of second messenger signaling 
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stems from the work of Earl Sutherland in 1957 [29] when he discovered that the activity of liver 
phosphorylase is stimulated indirectly by hormones, requiring a “heat-stable factor” that was 
later identified as cAMP [30]. That work established a paradigm of cell signaling whereby a first 
messenger (e.g., hormone or neurotransmitter) activates a receptor on the cell surface 
(canonically a GPCR) and activation of an intracellular effector molecule that produces the 
second messenger molecule. This process serves to greatly amplify the intracellular response 
since activation of just one receptor can lead to the production of multiple second messenger 
molecules. Since the discovery of cAMP, several other second messengers have been identified, 
including cGMP [32], inositol trisphosphate [33, 34], diacylglycerol [35], and calcium [36, 105]. 
Each of these molecules was painstakingly identified through rudimentary biochemical methods. 
With advances in metabolomics technologies however, we now have the ability to examine a 
broad complement of small molecules in a single experiment.  
In yeast, BCAAs are catabolized through the Ehrlich pathway. The end products of this 
pathway are fusel alcohols or fusel acids [99]. Much like the catabolism of BCAAs by the 
Ehrlich pathway in yeast, BCAAs in mammals are metabolized to 2-keto acids by the branched-
chain amino acid transaminases (BCATs). The 2-keto acids primarily undergo oxidative 
decarboxylation by branched-chain keto acid dehydrogenase (BCKDH) to yield substrates for 
further oxidation and generation of anaplerotic compounds for the TCA cycle [106]. 
Alternatively, 2-keto acids can be reduced to form the 2-hydroxy acids that are the subject of this 
research. Excess levels of 2-hydroxy acids are found in human patients with maple syrup urine 
disease (MSUD), also known as branched-chain ketoaciduria. This is an autosomal recessive 
disorder caused by a deficiency in BCKDH activity. Without this enzyme, 2-keto acids 
accumulate and are shunted towards formation of 2-hydroxy acids [107]. Accumulation of 2-keto 
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and 2-hydroxy acids often results in brain damage due to impaired neurotransmitter function 
caused by inhibition of glutamate uptake [108, 109], and neuronal energy metabolism 
dysfunction [110, 111]. Although 2-hydroxy acids are produced, the accumulation of BCAAs 
and 2-keto acids seems to have the greater impact on the pathophysiology of MSUD [112].  
Previously we showed that osmotic stress dampens and delays the mating pheromone 
response in yeast [4]. Here we describe potential mechanisms of this cross-pathway regulation. 
While our analysis focused on yeast, several tissues routinely experience osmotic stress, and can 
develop disease if osmoregulation is impaired. For example, osmotic stress can promote dry eye 
disease [47] and diabetic retinopathy [48]. High osmolarity in the vasculature can lead to 
hypertension [51] and a hyperosmolar hyperglycemic state in diabetics [49]. Importantly, BCAA 
metabolism is also conserved in humans [113]. Reduced levels of the BCAAs are observed in 
heart failure, sepsis, trauma, and burn injury [114]. Moreover, a reduction in the expression of 
BCATs and BCKDH, as well as an increase in the levels of 2-keto acids, have been identified as 
hallmarks of heart failure [115]. However the connection between osmotic stress signaling and 
BCAA metabolism is not clearly understood. Collectively, these examples highlight the need for 
a more complete understanding of the osmotic stress response and of BCAA metabolism. 
In summary, we identified 2-hydroxy BCAA derivatives as candidate second messengers 
of the osmotic stress pathway. As second messengers, these molecules are likely used to amplify 
the osmotic stress response and coordinate responses to hormones and neurotransmitters. A 
challenge for the future is to determine the mechanism by which Hog1 (or p38) promotes BCAA 
derivative accumulation, their cellular target(s) in both yeast and humans, as well as their 
potential as lead molecules for pharmacological control of the stress response in a mammalian 
system. 
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Materials and Methods 
Strains and Plasmids 
 All strains were generated from the BY4741 wild type strain (MATa his3Δ1 leu2Δ0 
met15Δ0 ura3Δ0) [116]. Gene deletion strains were generated by homologous recombination of 
PCR-amplified drug resistance genes from the pFA6a-KanMX6 [117] or pFA6a-hphMX6 
plasmids [118], with flanking sequence homologous to the gene of interest [119], or by the 
delitto perfetto method, leaving no selection marker [120]. Similarly, Flag-tagged strains were 
generated by homologous recombination of the PCR-amplified cassette from pFA6a-6xGly-
3xFlag-HIS3MX6 [121], with flanking sequence homologous to either side of the stop codon of 
the gene of interest. Bat1
5A
 Bat2
3A
 non-phosphorylatable mutants were generated using the 
delitto perfetto method. BAT1 was replaced with the CORE cassette and then with synthesized 
BAT1-5A. The same steps were then used to replace BAT2 with BAT2-3A. All cells were grown 
at 30°C unless otherwise noted. 
 The pRS426-PFUS1-YeGFP3 plasmid was generated by subcloning the YeGFP3 gene 
[122] under control of the yeast FUS1 promoter from pDS30 (from Daria Siekhaus, University 
of California, Berkeley) [123] into pRS426 [124], by digestion with BamHI and XhoI, and 
ligation of gel-purified products. pYEplac181-pHluorin (2μ, ampR, LEU2+) was the gift of Rajini 
Rao (Johns Hopkins University) [84, 94, 95]. 
Environmental Stress Timecourses 
 Cells were grown to saturation overnight in SCD medium, diluted to OD600 = 0.10, grown 
to OD600 ~0.6-0.8, then diluted again and grown to OD600 ~1.0. Aliquots were mixed 19:1 with 
6.1 N trichloroacetic acid (TCA) and placed on ice. SCD or SCD containing 3x stress stimulus 
was added to the experimental cell cultures. Aliquots were collected at the times indicated, added  
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Table 2.2  Yeast strains used in this study. 
Strain Name Genotype Source 
BY4743 MATa/α leu2Δ0/ leu2Δ0 LYS2/lys2Δ0 
met15Δ0/MET15 his3-1/ his3-1 ura3Δ0/ 
ura3Δ0 
(Brachmann et al. 
1998) 
BY4741
a
 MATa leu2Δ0 met15Δ0 his3-1 ura3Δ0 (Brachmann et al. 
1998) 
hog1Δ MATa hog1Δ0 This study 
hog1
K52R 
MATa hog1
K52R 
(Hao et al. 2007) 
bat1Δ MATa bat1::KanMX4 This study 
bat2Δ MATa bat2::HphMX6 This study 
TetO7-BAT1-FLAG 
bat2Δ 
MATa CMV-tTA-URA3 KanMX4-TetO7-PBAT1 
BAT1::6xGly-3xFLAG-HIS3MX6 
bat2::HphMX6 
This study 
pdr12Δ MATa pdr12::KanMX4 This study 
bat1
5A
 bat2
3A 
MATa bat1
T68A, T101A, T175A, S186A, S339A 
bat2
T51A, 
T158A, S322A
 
This study 
BAT1-Flag MATa BAT1-6xGly-3xFLAG-HIS3MX6 This study 
bat1
5A
-Flag MATa bat1
T68A, T101A, T175A, S186A, S339A
-6xGly-
3xFLAG-HIS3MX6 
This study 
bat1
5A
-Flag bat2Δ MATa bat1T68A, T101A, T175A, S186A, S339A-6xGly-
3xFLAG-HIS3MX6 bat2::HphMX6 
This study 
BAT2-Flag MATa BAT2-6xGly-3xFLAG-HIS3MX6 This study 
bat2
3A
-Flag
 
MATa bat2
T51A, T158A, S322A
-6xGly-3xFLAG-
HIS3MX6 
This study 
bat1Δ bat23A-Flag MATa bat1::KanMX4 bat2T51A, T158A, S322A-
6xGly-3xFLAG-HIS3MX6 
This study 
elm1Δ MATa elm1::KanMX4 (Clement et al. 2013) 
sak1Δ MATa sak1::KanMX4 (Clement et al. 2013) 
tos3Δ MATa tos3::KanMX4 (Clement et al. 2013) 
elm1Δ sak1Δ MATa elm1::URA3 sak1::KanMX4 (Clement et al. 2013) 
elm1Δ tos3Δ MATa elm1::URA3 tos3::KanMX4 (Clement et al. 2013) 
sak1Δ tos3Δ MATa sak1::URA3 tos3::KanMX4 (Clement et al. 2013) 
elm1Δ sak1Δ tos3Δ MATa elm1Δ0 sak1::URA3 tos3::KanMX4 This study 
elm1Δ sak1Δ tos3Δ MATa elm1Δ::URA3 sak1::LEU2 
tos3::KanMX4 
(Clement et al. 2013) 
reg1Δ MATa reg1::KanMX4 (Clement et al. 2013) 
a
All strains were derived from BY4741 
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Table 2.3  Plasmids used in this study. 
Plasmid Name Descripion Source 
pYEplac181 2μ, ampR, LEU2+, PTEF1-
pHluorin 
(Isom et al. 2013) Dr. Rajini Rao,  
Johns Hopkins 
pRS426-PFUS1-YeGFP3 2μ, amp
R
, URA3+, PFUS1-
YeGFP3 
This Study 
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to TCA, and placed on ice. Cell pellets were collected by centrifugation at 1962 x g for 2 
minutes, and resuspended in 10 mM NaN3. Cells were collected by centrifugation at 16,060 x g 
for 1 minute, the supernatant was removed, and cell pellets were stored at -80°C until use. 
 Heat shock experiments were carried out by growing cells as indicated above, then 
transferring the cultures to a 42°C water bath incubator/shaker and adding 1/3 final volume of 
SCD medium pre-warmed to 42°C. 
For glucose limitation experiments, wild-type cells were grown as above to an OD600 
~0.8, collected by centrifugation at 1962 x g for 2 minutes, resuspended with one-quarter volume 
of glucose-free SCD medium, centrifuged again and resuspended in original volume SCD 
medium containing either 2% or 0.05% glucose. Note that centrifugation alone leads to partial 
Gpa1 phosphorylation (Figure 1A, 2% Glucose curve). 
Standard SDS-PAGE and Immunoblotting 
Cell Lysis and Protein Quantification 
 Cell pellets were thawed on ice, and resuspended in ice cold TCA buffer (10 mM Tris-
HCl, pH 8.0, 10% TCA, 25 mM ammonium acetate, 1 mM ethylenediaminetetraacetic acid). 
Cells were vortexed for 10 minutes, then collected by centrifugation at 16,060 x g for 10 minutes 
at 4°C. Pellets were reconstituted in resuspension buffer (100 mM Tris-HCl, pH 11.0, 3% 
sodium dodecyl sulfate (SDS)), heated at 99°C for 10 minutes, cooled to room temperature for 
10 minutes, and centrifuged at 16,060 x g for 1 minute. Lysates were transferred to new tubes 
and 5 μL was used in a Bio-Rad DC Protein Assay (Bio-Rad #5000112), carried out according to 
the manufacturer’s protocol, and compared against a bovine serum albumin standard curve. 
Lysates were normalized to 2 μg/μL with resuspension buffer and 6x SDS sample buffer (350 
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mM Tris-HCl, pH 6.8, 30%(v/v) glycerol, 10%(w/v) SDS, 600 mM dithiothreitol, 0.012%(w/v) 
bromophenol blue), and used immediately or stored at -80°C. 
Immunoblotting 
 Cell lysates were heated at 99°C for 10 minutes, then 40 μg of protein was loaded onto 
10% SDS-PAGE gels. Gels were then run in SDS electrophoresis buffer (25 mM Tris base, 20 
mM glycine, 0.1%(w/v) SDS) at room temperature for 20 minutes at 20 mA/gel after which, 
current was increased to 25 mA/gel for 110 minutes. Electrophoresed proteins were then 
transferred to nitrocellulose membranes at 100 V for 90 minutes at 4°C in transfer buffer (20% 
methanol, 25 mM Tris Base, 200 mM glycine). Membranes were blocked in TBS-T (100 mM 
Tris Base, 150 mM NaCl, 0.1% Tween-20, pH 7.5) containing 5% (w/v) milk and 10 mM NaN3 
for 1 hour unless otherwise indicated. Western blots were probed with antibodies raised against 
Gpa1 (in-house rabbit polyclonal antibody, 1:1,000 ratio) [125], phospho-Snf1 (phospho-
AMPKα (Thr172) 40H9 Rabbit mAb, Cell Signaling Technology #2353, 1:2,000 ratio), Snf1 
(poly histidine HIS-1 mouse mAb, Sigma-Aldrich #H1029, 1:3,000 ratio), Hog1 (Santa Cruz 
Biotechnology #sc-6815, 1:500 ratio), phospho-Hog1 (phospho-p38 MAPK (Thr180/Tyr182) 
28B10 Mouse mAb, Cell Signaling Technology #9216, 1:500 ratio), and Glucose-6-phosphate 
dehydrogenase as a loading control (G6PDH, Sigma # A9521, 1:50,000 ratio). Blots were 
incubated with primary antibodies for 1 hour to overnight, washed 3 x 5 minutes with TBS-T, 
then incubated with horseradish peroxidase-conjugated secondary antibodies raised against 
rabbit (Bio-Rad #1662408), mouse (Bio-Rad #1721011), or goat (Santa Cruz Biotechnology #sc-
2768) at a 1:10,000 ratio in TBS-T containing 5% (w/v) milk, and washed 3 x 5 minutes with 
TBS-T. Blots were imaged on a Bio-Rad ChemiDoc MP imaging system after a 5 minute 
incubation with Clarity ECL Western Blotting Substrate (Bio-Rad #1705061).  
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Phos-tag SDS-PAGE and Immunoblotting 
Cell Lysis and Protein Quantification 
 Frozen cell pellets were collected as described above. Cell pellets were thawed on ice, 
and resuspended in ice cold TCA buffer without EDTA (10 mM Tris-HCl, pH 8.0, 10% TCA, 25 
mM ammonium acetate). Cells were lysed and lysate protein content was determined by the Bio-
Rad DC Protein Assay as described above. Lysates were normalized to 1.5 μg/μL with 
resuspension buffer and 2x SDS sample buffer (500 mM Tris-HCl, pH 8.5, 20%(v/v) glycerol, 
2%(w/v) SDS, 200 mM dithiothreitol, 0.01%(w/v) bromophenol blue), and used immediately or 
stored at -80°C. 
Phos-tag bis-tris acrylamide gel preparation and transfer for immunoblotting 
 8% bis-tris SDS-PAGE gels containing 20 μM Phos-tag and 40 μM Zn(NO3)2 were 
prepared, run and transferred as described previously [126]. Briefly, protein samples were heated 
at 70°C for 10 minutes, then 15 μg of protein per lane was loaded onto Phos-tag gels. Gels were 
then run in phos-tag SDS-PAGE electrophoresis buffer (50 mM Tris base, 50 mM MOPS, 
0.1%(w/v) SDS, 5mM sodium bisulfite, pH 7.2) at room temperature 150V for 90 minutes. 
Resolving layers were removed and equilibrated in transfer buffer (1x NuPAGE transfer buffer 
(Life Technologies # NP0006-1), 20%(v/v) methanol, 2.5 mM sodium pyrophosphate, 5 mM 
sodium bisulfite) for 15 minutes at room temperature with shaking to release phopho-proteins 
from Phos-tag. Electrophoresed proteins were then transferred to polyvinylidene difluoride 
(PVDF) membranes (Millipore # IPVH00010) 20 V for 20 hours at 4°C.  
Immunoblotting 
Membranes were blocked in TBS-T (100 mM Tris Base, 150 mM NaCl, 0.1% Tween-20, pH 
7.5) containing 5% (w/v) milk and 10 mM NaN3 for 1 hour. Membranes were then probed for 
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Flag-tagged proteins using the anti-Flag M2 primary antibody (Sigma # F3165) at a 1:10,000 
ratio in blocking buffer, and Glucose-6-phosphate dehydrogenase as a loading control (G6PDH, 
Sigma # A9521, 1:50,000 ratio). Blots were incubated with primary antibodies for 1 hour, 
washed 3 x 5 minutes with TBS-T, then incubated with horseradish peroxidase-conjugated 
secondary antibodies raised against rabbit (Bio-Rad #1662408), or mouse (Bio-Rad #1721011) at 
a 1:10,000 ratio in TBS-T containing 5% (w/v) milk for 1 hour, and washed 3 x 5 minutes with 
TBS-T. Blots were imaged on a Bio-Rad ChemiDoc MP imaging system after a 5 minute 
incubation with Clarity ECL Western Blotting Substrate (Bio-Rad #1705061). 
Intracellular pH Measurements 
 Wild type yeast were transformed with plasmid pYEplac181-pHluorin [84, 94, 95] and 
grown in SCD-Leu medium. For cells treated with BCAA derivatives (30 mM) the medium was 
titrated to pH 5.0 with HCl. Experiments and pHi calculations were carried out as in [84] using 
the indicated stressor or metabolite at 3x stock concentration. 
Metabolomics 
 Wild type and hog1Δ cells were grown to saturation overnight, diluted to OD600 = 0.10 
grown to OD600 ~0.6, diluted again to OD600 = 0.00075, incubated overnight at to OD600 ~0.9. 
Cultures were then split in half and grown to OD600 ~1.0 and mixed 1:4 with SCD or SCD plus 
2.5M KCl. After 3 minutes the cultures were transferred to 250 mL conical bottles (Corning 
#430776) and centrifuged for 3 minutes at 2,500 rpm (1819.3 x g) in a Sorvall RC3C Plus 
centrifuge using an H6000A swinging bucket rotor. After aspirating the supernatant the cell 
pellets were snap-frozen in place with liquid nitrogen and stored at -80°C. The cells were 
exposed to KCl for a total of 20 minutes. Frozen pellets were submitted to Metabolon, Inc. for 
GC-MS and LC-MS/MS analysis of metabolites. 
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Sample Preparation 
Samples were stored at –70°C until processed. Sample preparation was carried out as 
described previously [71] at Metabolon, Inc.  Briefly, recovery standards were added prior to the 
first step in the extraction process for quality control purposes.  To remove protein, dissociate 
small molecules bound to protein or trapped in the precipitated protein matrix, and to recover 
chemically diverse metabolites, proteins were precipitated with methanol under vigorous shaking 
for 2 min  followed by centrifugation.  The resulting extract was divided into four fractions: one 
for analysis by ultra high performance liquid chromatography-tandem mass spectrometry 
(UPLC-MS/MS; positive mode), one for analysis by UPLC-MS/MS (negative mode), one for 
analysis by gas chromatography–mass spectrometry (GC-MS), and one sample was reserved for 
backup. 
Three types of controls were analyzed in concert with the experimental samples: samples 
generated from a pool of each experimental sample served as technical replicates throughout the 
metabolomics platform run; extracted water samples served as process blanks; and a cocktail of 
standards spiked into every analyzed sample allowed instrument performance monitoring. 
Instrument variability was determined by calculating the median relative standard deviation 
(RSD) for the standards that were added to each sample prior to injection into the mass 
spectrometers (median RSD = 5; n = 29 standards). Overall process variability was determined 
by calculating the median RSD for all endogenous metabolites (i.e., non-instrument standards) 
present in 100% of the pooled yeast technical replicate samples (median RSD = 9%; n = 296 
metabolites). Experimental samples and controls were randomized across the platform run. 
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Mass Spectrometry Analysis 
Non-targeted MS analysis was performed at Metabolon, Inc.  Extracts were subjected to either 
GC-MS [127] or UPLC-MS/MS[71].  The chromatography was standardized and once the 
method was validated, and no further changes were made.  As part of Metabolon’s general 
practice, all columns were purchased from a single manufacturer’s lot at the outset of 
experiments.  All solvents were similarly purchased in bulk from a single manufacturer’s lot in 
sufficient quantity to complete all related experiments.  For each sample, vacuum-dried samples 
were dissolved in injection solvent containing eight or more injection standards at fixed 
concentrations, depending on the platform.  The internal standards were used both to assure 
injection and chromatographic consistency.  Instruments were tuned and calibrated for mass 
resolution and mass accuracy daily. 
The UPLC-MS/MS platform utilized a Waters Acquity UPLC and a ThermoFisher LTQ 
mass spectrometer, which included an electrospray ionization source and a linear ion-trap mass 
analyzer. The instrumentation was set to monitor for positive ions in acidic extracts or negative 
ions in basic extracts through independent injections.  The instrument was set to scan 99–1000 
m/z and alternated between MS and MS/MS scans.  The scan speed was approximately six scans 
per s (three MS and three MS/MS scans).  MS/MS scans were collected using dynamic 
exclusion, a process in which after an MS/MS scan of a specific m/z has been obtained, then that 
m/z is placed on a temporary MS/MS exclude list for a user-set period of time to allow greater 
MS/MS coverage of ions present in the MS scan because the instrument will not trigger an 
MS/MS scan of the same ion repeatedly.  Extracts were loaded onto columns (Waters UPLC 
BEH C18-2.1×100 mm, 1.7 µm) and gradient-eluted with water and 95% methanol containing 
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0.1% formic acid (acidic extracts) or 6.5 mM ammonium bicarbonate (basic extracts).  Columns 
were washed and reconditioned after every injection. 
The samples destined for analysis by GC-MS were dried under vacuum desiccation for a 
minimum of 18 h prior to being derivatized under dried nitrogen using bistrimethyl-
silyltrifluoroacetamide.  Derivatized samples were separated on a 5% phenyldimethyl silicone 
column with helium as carrier gas and a temperature ramp from 60° to 340°C within a 17-min 
period.  All samples were analyzed on a Thermo-Finnigan Trace DSQ MS operated at unit mass 
resolving power with electron impact ionization and a 50–750 atomic mass unit scan range. 
Compound Identification, Quantification, and Data Curation 
Metabolites were identified by automated comparison of the ion features in the 
experimental samples to a reference library of chemical standard entries that included retention 
time, molecular weight (m/z), preferred adducts, and in-source fragments as well as associated 
MS spectra and curated by visual inspection for quality control using software developed at 
Metabolon [128].  Identification of known chemical entities is based on comparison to 
metabolomic library entries of purified standards.  Over 4,000 commercially available purified 
standard compounds have been acquired and registered into LIMS for distribution to both the 
LC/MS and GC/MS platforms for determination of their detectable characteristics.  Peaks were 
quantified using area under the curve. 
NMR Spectroscopy 
For NMR measurements, 
15
N-enriched Gαi-Δ31 produced as in [129] was exchanged into NMR 
buffer (20 mM sodium phosphate, pH 7.0, 50 mM NaCl, 2 mM MgCl2, 200 μM GDP, 5% D2O). 
Each NMR sample contained 50 μM Gαi-Δ31 and 1.25 mM ligand. NMR spectra were acquired 
at 25 °C on a Bruker Avance 850 NMR spectrometer. Two-dimensional 
1
H–15N HSQC 
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experiments were recorded with 1024 and 128 complex points in the direct and indirect 
dimensions, respectively, 44 scans per increment and a recovery delay of 1.0 s. Spectral widths 
used were 13586.957 Hz (
1
H) and 3015.682 (
15
N) Hz. Spectra were processed and analyzed 
using NMRPipe (NIDDK, NIH) and Sparky (UCSF).  
Transcriptional Reporter Assay 
 Four colonies of the same strain transformed with plasmid pRS426-PFUS1-YeGFP3 and 
one colony of the untransformed background strain (to use for background fluorescence 
subtraction) were grown to OD600 ~1.0. Cells were added in duplicate to black clear-bottomed 
96-well plates containing 10x stocks of serially diluted α-factor mating pheromone ranging in 
concentration from 1x10
-4.5
 M to 1x10
-10
 M prepared in sterile water, and 5x stocks of stimulus 
solution prepared in growth medium. The OD600 for each well was measured for cell number 
normalization. After 3 hours GFP fluorescence was measured at an excitation wavelength of 485 
nm, and emission wavelength of 538 nm, using a cutoff of 530 nm, in a Molecular Devices 
Spectramax M5 plate reader. For data presentation, raw fluorescence values from each well were 
normalized to the number of cells in that well (represented by the OD600) using the shorthand 
Taylor Series 
1
1+𝑥
 where x = OD600. Normalized values of each technical duplicate were 
averaged, and normalized values from the background strain (containing no fluorescence 
reporter) were subtracted. Finally, each well was normalized as a percent to the average 
maximum fluorescence value in the α-factor only treated positive control. Dose-response curves 
were fitted using a nonlinear Boltzmann function. 
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Statistical Analysis 
 All data are reported as mean ± the standard deviation. Statistical significance was 
determined by an unpaired two-sided student’s t-test. In all cases, a p-value ≤ 0.05 was 
considered to be statistically significant. 
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CHAPTER 3 – COMPARATIVE METHODS ANALYSIS FOR MEASURING MAPK- 
AND TRANSCRIPTIONAL ACTIVATION IN THE YEAST PHEROMONE RESPONSE 
PATHWAY 
Summary 
  The pheromone response pathway of the yeast S. cerevisiae is a well-established model 
for the study of G proteins and mitogen-activated protein kinase (MAPK) cascades. Our long-
standing ability to combine gene editing with quantitative activity assays has provided a 
thorough understanding of pathway function and regulation. The pheromone response pathway 
has been used as a workhorse in drug screening platforms seeking to identify new therapeutics 
that target mammalian G protein signaling pathways. Additionally, assays monitoring phospho-
MAPK levels and pathway-specific transcriptional reporters are routinely used to study 
perturbations to upstream G protein signaling. The long-standing methods used to measure these 
signaling events are immunoblotting with phospho-specific antibodies for MAPK activation, and 
pathway-specific β-galactosidase assays for transcriptional activation. Recent technological 
advances have garnered new, alternative methods to probe the pheromone response pathway at 
the level of MAPK activation and transcription, specifically Phos-tag immunoblotting and GFP-
based transcriptional activity assays. Here, we compare gold-standard methods with these newer 
and alternative technologies in wild-type yeast and a bar1Δ mutant strain with increased 
sensitivity to pheromone. We highlight important differences between newer and established 
methodologies, and compare the advantages and disadvantages of each as applied to the yeast 
model.  
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Introduction 
The pheromone response pathway of the budding yeast Saccharomyces cerevisiae is a 
mitogen-activated protein kinase (MAPK) pathway that is regulated by a G protein-coupled 
receptor (GPCR) and heterotrimeric G protein, and thus serves as an ideal system in which to 
study both G protein and MAPK signaling. Indeed, the first MAPKs [130, 131] and MAPK 
signaling cascades were identified in yeast [132-135]. Additionally, yeast serves as a model 
system for studying fundamental mechanisms of GPCR signal regulation. In addition to its use as 
a simple system for studying cell signaling, the yeast pheromone response pathway has been 
modified and employed for use as a screening platform for directed evolution of designer 
receptors [136, 137], identifying new human GPCR agonists, antagonists, and modulators [138, 
139] (reviewed in [140]), as well as studying the effects of toxicants on GPCR pathways [141].  
The pheromone response pathway initiates events necessary for mating of haploid a- and 
α cells. These cells secrete specific pheromones, a-factor and α-factor, which bind to cognate 
receptors on cells of the opposite type. Since a-factor is prenylated and difficult to isolate, most 
work is done with α-factor and the GPCR Ste2. Once activated, the receptor promotes the 
exchange of GDP for GTP in the Gα subunit, Gpa1, and subsequent dissociation of the Gβγ 
complex, Ste4/18. Ste4/18 then binds to the p21-activated kinase (PAK), Ste20, and the scaffold 
protein, Ste5 recruiting the components of the MAPK signaling cascade— the MAPKKK Ste11, 
the MAPKK Ste7, and the MAPK Fus3 [142, 143]. A homologous MAPK, Kss1, is also 
activated by Ste7, but binds poorly to Ste5, and this interaction is not required for Kss1 
activation [62, 144, 145]. Either MAPK phosphorylates the transcription factor Ste12, which 
promotes transcription of pheromone-specific genes, including FUS1, to prepare the cell for 
mating [63, 64].  
 63 
 
A comprehensive understanding of any signaling pathway requires quantitative measures 
of pathway activation. High-throughput assays, such as those used to screen for drugs acting on 
GPCRs, have also taken advantage of transcriptional reporters using the FUS1 promoter fused to 
reporter genes including LacZ (encoding β-galactosidase), fluorescent proteins (e.g. GFP), drug 
resistance genes, and auxotrophic marker genes. 
Here, we compare two methods for measuring the phosphorylation of the MAPKs Fus3 
and Kss1 by immunoblotting—phospho-specific antibodies, and Phos-tag immunoblot analysis. 
We also compare two different transcriptional reporters—the enzyme-based PFUS1-LacZ (or β-
galactosidase) assay, and the fluorescent protein-based PFUS1-GFP assay. We compare the 
advantages and disadvantages of each method, provide experimental data to illustrate their use, 
and discuss experimental scenarios where each method is favored. 
 
Materials and Methods 
Strains and Plasmids 
All strains were generated from the BY4741 wild-type background [116]. Genetic 
deletion of BAR1 was achieved by homologous recombination of the PCR-amplified G418 drug 
resistance gene from the pFA6a-KanMX6 [117] plasmid, with flanking sequence homologous to 
the BAR1, transformed by lithium acetate transformation [119]. Similarly, Kss1-9xMyc-tagged 
wild-type and bar1Δ strains were generated by homologous recombination of the PCR-amplified 
9xMyc cassette with resistance to hygromycin B from the pYM20 plasmid (pYM-9xMyc-
hphNT1) [146], with flanking sequence homologous to either side of the stop codon of KSS1. 
The pRS426-PFUS1-YeGFP3 plasmid was generated by subcloning the YeGFP3 gene [122] under 
control of the yeast FUS1 promoter from pDS30 (from Daria Siekhaus, University of California, 
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Berkeley) [123] into pRS426 [124] by digestion with BamHI and XhoI, and subsequent ligation 
of gel-purified products. The pRS423-PFUS1-LacZ plasmid was generated previously [147]. 
Phospho-MAPK Time Courses 
Cells were grown to saturation overnight in SCD medium at 30°C. Cultures were diluted 
with SCD medium to OD600 = 0.10 and grown until OD600 ~0.6-0.8, then diluted again and 
grown to an OD600 ~1.0. An aliquot was collected for the 0 minute time point, added to 6.1 N 
trichloroacetic acid (TCA) to achieve 5% final TCA concentration, and placed on ice. For 
pheromone stimulation, 1000x α-factor was added to a final concentration of 3 μM or 0.3 μM 
(diluted from the same stock). Cultures were incubated at 30°C, and aliquots were collected at 5, 
15, 30, 60, and 90 minutes, added to TCA, and placed on ice. Cell pellets were collected by 
centrifugation at 1962 x g for 2 minutes, and then washed with 10 mM NaN3. Pellets were 
recollected by centrifugation at 16,060 x g for 1 minute, supernatant was removed, and pellets 
were stored at -80°C until use. 
Cell Lysis and Protein Quantification 
The same cell lysates were used for both conventional- and Phos-tag SDS-PAGE, and 
were prepared using optimal conditions for Phos-tag SDS-PAGE as described previously [126]. 
Cell pellets were thawed on ice, and resuspended in ice cold TCA buffer without EDTA (10 mM 
Tris-HCl, pH 8.0, 10% TCA, 25 mM ammonium acetate). Cells were vortexed for 10 minutes at 
4°C, then pelleted by centrifugation at 16,060xg for 10 minutes at 4°C. Pellets were resuspended 
in resuspension buffer (100 mM Tris-HCl, pH 11.0, 3% sodium dodecyl sulfate (SDS)), then 
heated at 99°C for 10 minutes, cooled to room temperature for 10 minutes, and centrifuged at 
16,060xg for 1 minute. 
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Lysates were transferred to new tubes and 5 μL were used in a Bio-Rad DC Protein 
Assay (Bio-Rad # 5000112) carried out per the manufacturer’s protocol. Absorbance values were 
compared against a bovine serum albumin standard curve ranging from 0-10 μg/μL prepared in 
resuspension buffer. Lysates were normalized to 2 μg/μL with resuspension buffer and 2x SDS 
sample buffer (500 mM Tris-HCl, pH 8.5, 20% (v/v) glycerol, 2% (w/v) SDS, 200 mM 
dithiothreitol, 0.01% (w/v) bromophenol blue), and used immediately or stored at -80°C. For 
use, samples were heated at 70°C for 10 minutes prior to loading. 
Conventional SDS-PAGE and Immunoblotting 
30 μg of protein sample were loaded onto 10% SDS-PAGE gels. Gels were then run in 
SDS electrophoresis buffer (25 mM Tris base, 20 mM glycine, 0.1% (w/v) SDS) at room 
temperature for 20 minutes at 20 mA/gel for even migration of protein into the stacking layer, 
after which, current was increased to 25 mA/gel for 110 minutes. Electrophoresed proteins were 
then transferred to nitrocellulose membranes at 100 V for 90 minutes at 4°C in transfer buffer 
(20% methanol, 25 mM Tris Base, 200 mM glycine).  
Membranes were blocked in TBS-T (100 mM Tris Base, 150 mM NaCl, 0.1% Tween-20, 
pH 7.5) containing 5% (w/v) non-fat dry milk and 10 mM NaN3 for 1 hour. Western blots were 
probed with antibodies specific for phospho-p44/42 MAPK, raised against a phosphorylated 
MAPK peptide (Cell Signaling # 4370, 1:500 ratio), total Fus3 MAPK (Santa Cruz 
Biotechnology # 6773 ,1:500 ratio), total Kss1-Myc (Myc-Tag (9B11) Mouse mAb, Cell 
Signaling Technology # 2276, 1:1,000 ratio), and glucose-6-phosphate dehydrogenase (G6PDH) 
as a loading control (Sigma # A9521, 1:50,000 ratio). Blots were incubated with primary 
antibodies diluted in blocking buffer overnight with shaking, except for G6PDH, which was 
incubated for 1 hour. Blots were washed 3 x 5 minutes with TBS-T, then incubated with 
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horseradish peroxidase-conjugated secondary antibodies raised against rabbit (goat anti-rabbit, 
Bio-Rad # 1662408), mouse (donkey anti-mouse, Jackson ImmunoResearch # 715-035-151), or 
goat (donkey anti-goat, Santa Cruz Biotechnology # sc-2020) at a 1:10,000 ratio in TBS-T 
containing 5% (w/v) non-fat dry milk for 1 hour, and then washed 3 x 5 minutes with TBS-T. 
Blots were imaged on a Bio-Rad ChemiDoc MP imaging system after a 5 minute incubation with 
Clarity ECL Western Blotting Substrate (Bio-Rad # 1705061). Blots were stripped of antibodies 
between probing for phospho-MAPK and total MAPK (combined anti-Fus3 and anti-Myc-Tag), 
and between probing for total MAPK and G6PDH loading control in stripping buffer (62.5 mM 
Tris-HCl (pH 6.8), 2% (w/v) SDS, 100 mM β-mercaptoethanol) at 65°C for 30 minutes in a dry 
oven with occasional agitation by hand. Stripped blots were rinsed thoroughly with distilled 
water, and then washed with TBS-T 3x10 minutes before re-probing.  
Phos-tag SDS-PAGE and Immunoblotting 
10% bis-tris SDS-PAGE gels containing 50 μM Phos-tag and 100 μM Zn(NO3)2 were 
prepared, ran and transferred as described previously [126]. Briefly, 15 μg of protein sample 
were loaded onto Phos-tag gels. Gels were then run in phos-tag SDS-PAGE electrophoresis 
buffer (50 mM Tris base, 50 mM MOPS, 0.1% (w/v) SDS, 5mM sodium bisulfite, pH 7.2) at 
room temperature 150V for 90 minutes. Resolving layers were removed and equilibrated in 
transfer buffer (1x NuPAGE transfer buffer (Life Technologies # NP0006-1), 20% (v/v) 
methanol, 2.5 mM sodium pyrophosphate, 5 mM sodium bisulfite) for 15 minutes at room 
temperature with shaking to release phopho-proteins from Phos-tag. Electrophoresed proteins 
were then transferred to polyvinylidene difluoride (PVDF) membranes (Millipore # IPVH00010) 
at 20 V for 20 hours at 4°C. 
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Membranes were blocked in TBS-T (100 mM Tris Base, 150 mM NaCl, 0.1% Tween-20, 
pH 7.5) containing 2% (w/v) fish gelatin (to reduce background fluorescence) and 10 mM NaN3 
for 1 hour. Membranes were then probed for total Fus3 MAPK and total Kss1-Myc 
simultaneously, diluted as above in TBS-T containing 0.5% fish gelatin and 10 mM NaN3, and 
for G6PDH as above. Blots were washed 3 x 5 minutes with TBS-T, then MAPK blots were 
incubated with fluorescent-conjugated secondary antibodies raised against donkey (Fus3: donkey 
anti-goat Alexa-647, Thermo Life Sciences # A-21447, 1:1,000 ratio; Kss1-Myc: donkey anti-
mouse Alexa-555, Thermo Life Sciences # A-31570, 1:1,000 ratio) diluted in TBS-T containing 
0.5% fish gelatin for 1 hour, and then washed 3 x 5 minutes with TBS-T. Membranes probed for 
G6PDH were probed with horseradish peroxidase-conjugated secondary antibodies raised 
against rabbit (Bio-Rad # 1662408, 1:10,000 ratio) in TBS-T containing 5% (w/v) milk for 1 
hour, and washed 3 x 5 minutes with TBS-T. MAPK blots were imaged on a Bio-Rad ChemiDoc 
MP imaging system using multichannel acquisition mode (Fus3, Alexa 647 channel; Kss1-Myc, 
Alexa546 channel) optimizing for intense bands after washing off excess secondary antibodies. 
G6PDH blots were imaged on a Bio-Rad ChemiDoc MP imaging system after a 5 minute 
incubation with Clarity ECL Western Blotting Substrate (Bio-Rad # 1705061). Blots were 
stripped as described above between probing for MAPK proteins (combined anti-Fus3 and anti-
Myc-Tag) and G6PDH loading control. 
Image Densitometry 
Densitometry analysis of band intensities was carried out in ImageJ [148] as described in 
[149]. Briefly, 16-bit raw TIF files were exported from the Bio-Rad Image Lab software and 
opened in ImageJ. Images were rotated to align bands horizontally, and the rectangle tool was 
used to select each lane for analysis. Rectangles were drawn to cover the entire width of the band 
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in one lane without causing overlap in other lanes, and were drawn long enough to sample the 
background pixel intensities surrounding the band(s) of interest. Upon selection of all lanes of 
interest, pixel intensity profiles were plotted, and background was subtracted by connecting the 
adjacent background intensities surrounding the peak corresponding to the band of interest using 
the line tool. The left and right sides of the peaks of interest were connected to the horizontal line 
created for background subtraction, effectively isolating roughly 95% of the Gaussian 
distribution. The magic wand tool was then used to obtain the area under the curve as the raw 
densitometry value. 
Transcriptional Reporter Assays 
Wild-type Kss1-Myc and bar1Δ Kss1-Myc strains were transformed with pRS423-PFUS1-
LacZ or pRS426-PFUS1-YeGFP3 by lithium acetate transformation as above and plated on SCD –
His or SCD –Ura selection medium, respectively, and incubated at 30°C for 2 days. Four 
colonies from each transformation were grown to saturation overnight in selection medium, then 
diluted to OD600 = 0.2 the following day and grown to OD600 ~0.6-0.8. These cultures were 
diluted to OD600 = 0.002 (GFP) or OD600 = 0.005 (LacZ) and grown overnight to an OD600 ~0.8. 
Then, 90 μL of cells from each of the four cultures per strain were added per well  in duplicate 
rows to black clear-bottomed 96-well plates containing 10 μL of 10x stocks of serially diluted α-
factor mating pheromone ranging in final concentration from 1x10
-4.5
 M to 1x10
-9
 M prepared in 
sterile water, with one well per row containing 10 μL of sterile water only.  
For PFUS1-GFP assays, plates were incubated for 1.5 hours at 30°C, then the OD600 for 
each well was measured to use for normalization, and GFP fluorescence was measured at an 
excitation wavelength of 483 nm, and emission wavelength of 518 nm. Plates were then read 
again for OD600 and GFP fluorescence at 2, 2.5, and 3 hours, incubating at 30°C between reads. 
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For PFUS1-LacZ assays were carried out as described previously [150]. Briefly, the OD600 
for each well was measured immediately after loading, and plates were incubated for 1.5 hours at 
30°C. After incubation, 20 μL fluorescein di-β-D-galactopyranoside (FDG) solution (135 mM 
PIPES, 0.25% (v/v) Triton X-100, 0.5 mM FDG, pH 7.2) was added, and the plates were 
incubated at 37°C for 1.5 hours. The reaction was stopped by addition of 20 μL of 1 M sodium 
carbonate, and fluorescence was measured at an excitation wavelength of 485 nm, and emission 
wavelength of 580 nm. All measurements were taken using a Molecular Devices Spectramax i3x 
plate reader.  
For data analysis and presentation, raw fluorescence values from each well were 
normalized to the number of cells in that well (represented by the OD600) using the shorthand 
Taylor Series 
1
1+𝑥
 where x = OD600. Normalized values of each technical duplicate were 
averaged. Finally, each well was normalized as a percent to the average maximum fluorescence 
value in the wild-type strain. Dose-response curves were fitted using a nonlinear Boltzmann 
function. 
 
Results and Discussion 
Our objective here is to disseminate methods that we use routinely to quantify the 
pheromone response in yeast. All of the assays are, in our experience, sufficiently robust and 
reliable for adoption in any well-equipped laboratory. The assays are downstream of the G 
protein, and include MAPK activation and MAPK-dependent gene transcription. To illustrate 
their ability to quantify differences in activity, we compare wild-type cells and mutants deficient 
in the secreted α-factor protease, Bar1. Cells lacking Bar1 (bar1Δ) exhibit elevated sensitivity to 
pheromone and sustained activation of the pathway [151-153]. Where activity is measured over 
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time, we compare the effects of two doses of pheromone—3 μM, and 0.3 μM, roughly 5-fold the 
EC50 of wild-type and bar1Δ cells, respectively. Transcriptional reporter experiments are done 
over a range of pheromone concentrations. 
MAPK activation measured by immunoblotting with phospho-MAPK antibodies 
Upon pheromone binding to the GPCR, Gβγ promotes the activation of a protein kinase 
cascade that culminates with the phosphorylation and activation of the terminal MAPKs Fus3 
and Kss1 [143]. In addition, FUS3 gene transcription is induced, resulting in an increase in Fus3 
protein levels over time [154]. Phosphorylation of MAPKs is commonly measured by 
immunoblotting using antibodies raised against a phosphorylated MAPK peptide (phospho-
p44/42), which recognize both phospho-Fus3 and phospho-Kss1. To account for changes in Fus3 
abundance, blots must then be stripped of phospho-specific antibodies and re-probed with 
antibodies against the total protein. Where commercial antibodies are unavailable, it is 
convenient to use an epitope-tagged version of the kinase of interest. In this case, we use 
commercial polyclonal antibodies to quantify Fus3, and monoclonal antibodies to quantify Myc-
tagged Kss1 (Kss1-Myc). Upon normalization to a loading control, changes in phosphorylation 
or total protein can be calculated. However, because it is necessary to probe blots once for 
phosphorylated protein, and again for total protein levels, the stoichiometry of protein 
phosphorylation cannot be calculated. This approach can give only the relative amount of protein 
phosphorylation. Furthermore, Fus3 is known to exist in both mono-phosphorylated and dually 
phosphorylated pools [155, 156], and the phospho-p44/42 antibody is able to detect, to an extent, 
mono-phosphorylated Fus3 in addition to dually phosphorylated Fus3 [157]. This is a concern 
because mono-phosphorylated Fus3 does not stimulate, but rather inhibits downstream signaling 
[156]. Results from this method, therefore, are only an approximation of kinase activation. 
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To illustrate the method, we measured Fus3 phosphorylation in wild-type and bar1Δ cells 
in response to a low (0.3 μM) and high (3 μM) dose of pheromone. In wild-type cells subjected 
to 0.3 μM pheromone, Fus3 reached ~80% of maximal phosphorylation achieved at the high 
dose by 5 minutes, and then phosphorylation slowly decreased to ~25% of maximum by 90 
minutes. At 3 μM pheromone, Fus3 reached ~70% of maximal phosphorylation achieved at this 
dose by 5 minutes, and continued to increase, reaching the maximum at 90 minutes (Figure3.1A, 
top graph). In contrast, bar1Δ cells subjected to 0.3 μM pheromone, Fus3 again reached ~80% of 
maximal phosphorylation by 5 minutes, but this level of phosphorylation was sustained through 
the duration of the experiment. Upon stimulation with 3 μM pheromone Fus3 reached ~60% of 
maximal phosphorylation by 5 minutes, and continued to increase, reaching the maximum at 60 
minutes before beginning to decline by 90 minutes (Figure 3.1B, top graph). These data are 
consistent with the fact that Bar1 degrades α-factor and thereby dampens the downstream signal 
over time. 
Part of the increase in Fus3 phosphorylation is due to an increase in Fus3 expression. To 
account for this we strip the blots and reprobe with Fus3 antibodies. In wild-type cells subjected 
to 0.3 μM pheromone, Fus3 abundance increased by ~100% by 30 minutes, and these levels 
remained constant through 90 minutes. At 3 μM pheromone, Fus3 was maximally increased by 
~150% by 60 minutes, and this level was sustained through 90 minutes (Figure 3.1A, middle 
graph). Induction occurred at a similar rate for 30 minutes, whereafter cells treated with the low 
dose remained at ~80% of that induced by the high dose. Fus3 induction was similar in wild-type 
and bar1Δ cells (Figure 3.1B, middle graph). Therefore, this analysis indicates that Bar1 limits 
Fus3 phosphorylation, but not Fus3 induction, at low doses of pheromone. 
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Figure 3.1  Phosphorylation of Fus3 by conventional SDS-PAGE and immunoblotting with 
phospho-p44-42 antibodies. 
Western blot analysis of (A) wild-type cells or (B) bar1Δ cells treated with 0.3 μM or 3 μM α-
factor mating pheromone were probed with phospho-p44/42 antibodies and total Fus3 antibodies. 
Phosphorylated Fus3 (top graphs) and total Fus3 (middle graphs) were plotted as % maximum 
signal on the blot. The phosphorylated Fus3 to total Fus3 ratio (bottom graphs) was calculated by 
dividing % maximum phosphorylated Fus3 by % maximum total Fus3. Data presented as mean ± 
standard deviation, N = 3.  
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There are two schools of thought for how activated MAPK transmits the pheromone 
response. The first argues that the proportion of protein that is phosphorylated dictates pathway 
output. The second argues that the absolute amount of phosphorylated MAPK in the cell is more 
important. While we do not attempt to resolve this issue here, data from MAPK analyses can be 
interpreted in light of downstream outputs such as Ste12 phosphorylation, transcription 
induction, growth arrest, or mating efficiency.  
We calculated the phosphorylated Fus3 to total Fus3 ratio for each dose of pheromone in 
wild-type and bar1Δ cells and plotted the ratio over time to demonstrate the differences between 
pheromone concentration and genotype. In wild-type cells, both doses of pheromone promoted 
rapid and robust phosphorylation of Fus3 by 5 minutes, while total Fus3 was only mildly 
induced, giving a ratio of ~1.5. Phosphorylation then declined in cells treated with the low dose, 
while Fus3 induction increased, thereby giving a ratio of <1 for the remainder of the experiment. 
In cells treated with the high dose, both phosphorylation and Fus3 induction continued to 
increase, giving a ratio of ~1 after 30 minutes (Figure 3.1A, bottom graph). In bar1Δ cells, 
phosphorylation increased proportionally with protein induction at both doses of pheromone, 
thus giving a ratio of 1 at all time points where pheromone was present (Figure 3.1B, bottom 
graph). 
While Fus3 activation requires scaffolding by Ste5 in addition to activated Ste7 for its 
phosphorylation, Kss1 does not require binding to Ste5 for its phosphorylation [145]. Kss1 is 
also part of the filamentous growth MAPK pathway, and so has distinct roles from Fus3 [158, 
159]. To understand differences between the activation of Fus3 and Kss1, we measured Kss1 
phosphorylation in wild-type and bar1Δ cells in response to the low and high doses of 
pheromone as for Fus3 above. Commercial antibodies are not available for Kss1, so we used a C-
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terminal 9xMyc-tagged version of Kss1, and probed with antibodies specific for the Myc tag to 
visualize Kss1. The same western blots used for the Fus3 analysis were probed for Kss1-Myc. 
The phsopho-p44/42 antibody recognizes phosphorylated Kss1, so both MAPKs (as well as a 
third MAPK, Slt2) were simultaneously detected (Slt2 data not shown). After stripping the blots, 
we re-probed for total Fus3 and Kss1 simultaneously by combining both the total Fus3 antibody 
and the anti-Myc-tag antibody in the same solution. Because the data for both Fus3 and Kss1 
were obtained from the same blots, the loading control was also the same for both proteins, and 
is presented in both Figure 3.1 and Figure 3.2. 
In wild-type cells subjected to the low, 0.3 μM dose of pheromone, Kss1 gave a nearly 
identical phosphorylation profile to that of Fus3. However, stimulation with the high, 3 μM dose 
of pheromone promoted maximal Kss1 phosphorylation by 5 minutes, and this phosphorylation 
was sustained through 90 minutes (Figure 3.2A, top graph). In contrast, bar1Δ cells subjected to 
the low dose for 5 minutes exhibited ~90% of maximal Kss1 phosphorylation attained by the 
high dose. Kss1 phosphorylation decreased to ~70% for the remainder of the experiment. At the 
high dose, bar1Δ cells exhibited ~70% Kss1 phosphorylation from 5 minutes through 90 minutes 
(Figure 3.2B, top graph). These data also corroborate that bar1Δ cells are supersensitive to 
pheromone, and Kss1, in addition to Fus3, is highly activated at lower doses of pheromone. 
We next measured Kss1 protein levels in response to the low and high pheromone doses, 
immunoblotting for the Myc tag. In wild-type cells subjected to either the low or high dose of 
pheromone, Kss1 showed no induction through the duration of the experiment (Figure 3.2A, 
middle graph). In bar1Δ cells subjected to the low dose exhibited modest induction at 5 minutes 
that then returned to base-line by 60 minutes. At the high dose, no induction was observed, and 
instead a slight reduction in Kss1 levels was observed by 90 minutes (Figure 3.2B, middle  
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Figure 3.2  Phosphorylation of Kss1 by conventional SDS-PAGE and immunoblotting with 
phospho-p44-42 antibodies. 
Western blot analysis of (A) wild-type cells or (B) bar1Δ cells treated with 0.3 μM or 3 μM α-
factor mating pheromone were probed with phospho-p44/42 antibodies and anti-Myc tag 
antibodies to identify Kss1. Phosphorylated Kss1 (top graphs) and total Kss1 (middle graphs) 
were plotted as % maximum signal on the blot. The phosphorylated Kss1 to total Kss1 ratio 
(bottom graphs) was calculated by dividing % maximum phosphorylated Kss1 by % maximum 
total Kss1. Data presented as mean ± standard deviation, N = 3.  
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graph). These data indicate that like Fus3, the increased pheromone sensitivity of bar1Δ cells 
results in increased phosphorylation of Kss1 at lower doses of pheromone rather than an increase 
in Kss1 induction. 
We also calculated the phosphorylated Kss1 to total Kss1 ratio for each dose of 
pheromone in wild-type and bar1Δ cells and plotted the ratio over time as done for Fus3 above. 
In wild-type cells, both doses of pheromone promoted maximal phosphorylation of Kss1 by 5 
minutes. The gradual dephosphorylation of Kss1 with no Kss1 induction resulted in a ratio of 1 
at 5 minutes that was gradually reduced to 0.25 by 90 minutes. In contrast, the high dose 
promoted sustained phosphorylation and no induction, resulting in a ratio of ~1 at all times 
where pheromone was present (Figure 3.2A, bottom graph). In bar1Δ cells, Kss1 
phosphorylation was sustained from 5 minutes through 90 minute at both doses of pheromone, 
and there was no substantial induction at either dose of pheromone, thus giving a ratio of near 1 
at all time points where pheromone was present (Figure 3.2B, bottom graph). 
Analysis by conventional immunoblotting with phospho-specific antibodies allows 
reliable comparison of different mutant strains and different doses of stimulus. This offers a 
more cost-effective alternative to the more-expensive Phos-tag approach when information on 
individual phospho-species is not required. The following section describes the use of Phos-tag 
gel electrophoresis to measure and calculate the stoichiometry of MAPK phosphorylation. 
MAPK activation measured by Phos-tag SDS-PAGE and immunoblotting 
Phosphate-binding tag, or Phos-tag  is a divalent-metal-coordinating small molecule that 
has a high affinity for phosphorylated serine, threonine, and tyrosine [160, 161]. By adding Phos-
tag and a divalent metal (e.g., Mn
2+
 or Zn
2+
) to acrylamide gels, the electrophoretic mobility of 
phosphorylated proteins is slowed, thereby separating phosphorylated species from non-
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phosphorylated species. Importantly, the number of bands is proportional to the number of 
phosphorylation events on the protein. Probing with antibodies specific for the protein of interest 
(e.g., Fus3) reveals all phosphorylated and non-phosphorylated protein species on the same blot. 
This allows a ratiometric quantification of each phospho-species. We have used Phos-tag SDS-
PAGE and immunoblotting to identify, quantify, and assign a negative-regulatory role to the 
mono-phosphorylated form of Fus3 [156], and to characterize dose-to-duration signaling as a 
mechanism for the MAPK, Hog1 [126]. 
To illustrate the data that can be collected by the Phos-tag method, we reanalyzed the samples 
used with phospho-specific antibodies above (Figure 3.1). As shown in Figure 3.3, we observed 
clear separation of the dually phosphorylated, mono-phosphorylated, and non-phosphorylated 
Fus3 species (Figure 3.3, top). By adding the band intensities in each lane and dividing out each 
band from the total amount, we calculated the percent of total Fus3 in a given phosphorylated 
state. At the low dose of pheromone, ~30% of Fus3 was dually phosphorylated, and ~25% of 
Fus3 was mono-phosphorylated. Phosphorylation declined after 5 minutes, with slightly more of 
the mono-phosphorylated species than the dually phosphorylated species (Figure 3.3A, top 
graph). These results are consistent with the model that Fus3 is first dually phosphorylated, and 
then singly dephosphorylated [156]. At the high pheromone dose, the dually phosphorylated 
species persisted at higher levels for longer, and exceeded the mono-phosphorylated pool until 
30 minutes. The mono-phosphorylated species increased steadily from 15 to 90 minutes, while 
the dually phosphorylated species decreased (Figure 3.3A, second graph), again consistent with a 
conversion from dual- to mono-phosphorylated species. These data also indicate that the increase 
observed by conventional immunoblotting (Figure 3.1A, top graph) is due in part to the increase 
in mono-phosphorylated Fus3.  
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Figure 3.3  Phosphorylation of Fus3 by Phos-tag SDS-PAGE and immunoblotting with 
Fus3 antibodies. 
Phos-tag western blot analysis of (A) wild-type cells or (B) bar1Δ cells treated with 0.3 μM or 3 
μM α-factor mating pheromone were probed with total Fus3 antibodies to identify dually 
phosphorylated (pp-Fus3), mono-phosphorylated (p-Fus3), and non-phosphorylated Fus3 (np-
Fus3). pp-Fus3, p-Fus3, and np-Fus3 (first and second graphs) were plotted as % of lane total. 
Total Fus3 (third graphs) were plotted as lane total as % maximum signal on the blot. The dually 
phosphorylated Fus3 to total Fus3 ratio (bottom graphs) was calculated by dividing the % dually 
phosphorylated Fus3 by % total Fus3. Data presented as mean ± standard deviation, N = 3.  
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In bar1Δ cells, pheromone stimulation at the low and high dose gave nearly identical 
results. Both phosphorylated species increased by 5 minutes to levels observed in wild-type cells, 
but the dually phosphorylated species persisted for 90 minutes, while the mono-phosphorylated 
species steadily increased (Figure 3.3B, top and second graph). These data are consistent with 
the supersensitivity of bar1Δ cells [151, 152]. 
We next analyzed Fus3 induction by plotting the total intensity of all bands in each lane 
as a percent of the maximum total signal on the blot (Figure 3.3 third graphs). We observed 
similar results to those obtained by conventional MAPK immunoblotting (Figure 3.1 middle 
graphs), however induction appeared to be stronger in the high dose in wild-type cells, and both 
doses in bar1Δ cells when analyzed by the Phos-tag method. This could be due in part to the 
stripping required in the conventional immunoblot analysis. 
Finally, we compared the fully active, dually phosphorylated Fus3 to total Fus3 ratio. 
Wild-type cells gave a similar profile to that obtained from conventional immunoblotting for 
both doses of pheromone (Figure 3.1A, bottom graph), with the exception that both curves were 
shifted down by a factor of 0.25, and the high dose continued to decline after 30 minutes (Figure 
3.3, bottom graph). In bar1Δ cells, we found that the profile for both doses was similar to the 
high dose in wild-type cells (Figure 3.3B, bottom graph). The rapid onset of dually 
phosphorylated Fus3 by 5 minutes and lack of induction at that time increases the ratio to ~1, but 
sustained activation and induced total Fus3 then drive the ratio down to 0.5 by 15 minutes and 
gradually to ~0.25 by 90 minutes. This is in opposition to the data obtained from conventional 
immunoblotting, where the ratio was increased to 1 by 5 minutes and remained there through 90 
minutes (Figure 3.1B, bottom graph). The discrepancies observed between the two methods 
could be due to the fact that the phospho-p44/42 antibody recognizes both the dually 
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phosphorylated MAPK as well as the mono-phosphorylated species [157]. Overall, the trends in 
Fus3 phosphorylation are similar to those observed by conventional immunoblotting (Figure 3.1, 
top graphs), however with the Phos-tag method, the actual percent phosphorylated protein is 
revealed, in addition to the individual phospho-species. 
Activation of Kss1 has not previously been analyzed by the Phos-tag method. As 
conventional immunoblotting identified differences between the phosphorylation and induction 
of Fus3 and Kss1, we also probed the Phos-tag blots used to analyze Fus3 with the anti-Myc tag 
antibodies in order to visualize Kss1. Blots were simultaneously probed with Fus3 and Myc-tag 
primary antibodies raised in different host species, and then probed with secondary antibodies 
conjugated to different fluorophores. Multi-channel fluorescence imaging allowed simultaneous 
detection of all phospho-species of both proteins. As with the conventional immunoblots above, 
the loading controls for the Phos-tag blots are the same, and are shown in both Figure 3.3 and 
Figure 3.4. 
Phos-tag analysis of Kss1 likewise revealed clear separation of the dually 
phosphorylated, mono-phosphorylated, and non-phosphorylated species (Figure 3.4, top). The 
low dose of pheromone promoted dual phosphorylation of ~60% of Kss1, twice that observed for 
Fus3. Dual phosphorylation then declined steadily, reaching basal levels by 90 minutes. Whereas 
Fus3 mono-phosphorylation increased to ~25%, Kss1 mono-phosphorylation increased to ~15% 
and was sustained through 90 minutes (Figure 3.4A, top graph). As with the low dose, the high 
dose of pheromone promoted dual phosphorylation of ~60% of Kss1 by 5 minutes, and this 
phosphorylation slowly declined to ~50% by 90 minutes. Mono-phosphorylated slowly increased 
to ~20% by 90 minutes (Figure 3.4A, second graph). In contrast to Fus3, the dually 
phosphorylated species of Kss1 always existed in a higher proportion than mono-phosphorylated  
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Figure 3.4  Phosphorylation of Kss1-Myc by Phos-tag SDS-PAGE and immunoblotting 
with Myc-Tag antibodies. 
Phos-tag western blot analysis of (A) wild-type cells or (B) bar1Δ cells treated with 0.3 μM or 3 
μM α-factor mating pheromone were probed with anti-Myc tag antibodies to identify dually 
phosphorylated (pp-Kss1), mono-phosphorylated (p-Kss1), and non-phosphorylated Kss1 (np-
Kss1). pp-Kss1, p-Kss1, and np-Kss1 (first and second graphs) were plotted as % of lane total. 
Total Kss1 (third graphs) were plotted as lane total as % maximum signal on the blot. The dually 
phosphorylated Kss1 to total Kss1 ratio (bottom graphs) was calculated by dividing the % dually 
phosphorylated Kss1 by % total Kss1. Data presented as mean ± standard deviation, N = 3.  
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Kss1. In bar1Δ cells, as with Fus3, pheromone stimulation at both doses gave nearly identical 
results for Kss1 phospho-species. Both phosphorylated species increased by 5 minutes to levels 
observed in wild-type cells, but with persistence of the dually phosphorylated species through 90 
minutes. The mono-phosphorylated species again slowly increased to ~20% as in wild-type cells 
treated with the high dose of pheromone (Figure 3.4B, top and second graph). Thus, results for 
Kss1 obtained by the Phos-tag method are consistent with those obtained by conventional 
immunoblotting (Figure 3.2). 
We next analyzed Kss1 induction as done for Fus3 above. We observed a small reduction 
in protein abundance by 5 minutes that then recovered to basal levels by 30 minutes in both wild-
type and bar1Δ cells Figure 3.4, third graphs). That there is relatively little change in the 
abundance of Kss1 over time is consistent with the findings obtained by conventional 
immunoblotting (Figure 3.2, middle graphs). 
Finally, we compared the fully active, dually phosphorylated Kss1 to total Kss1 ratio. As 
observed for Fus3, wild-type cells gave a similar profile for Kss1 to that obtained from 
conventional immunoblotting for both doses of pheromone (Figure 3.2A, bottom graph). Again, 
both curves were shifted down by a factor of 0.25 (Figure 3.4A, bottom graph). In bar1Δ cells, 
we found that the profile for both doses was similar the profiles obtained by conventional 
immunoblotting, within error (Figure 3.4B, bottom graph).  
We conclude that the use of phospho-specific antibodies allows reliable comparison of 
different mutant strains at different doses of stimulus. However, the Phos-tag method has several 
important advantages. First, the method allows easy detection of individual phospho-species, 
including the non-phosphorylated species, after probing with just one antibody. This allows 
ratiometric quantification of each phospho-species to give a precise measurement of the 
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percentage of phosphorylated protein in relation to the non-phosphorylated protein—a feature 
that is severely lacking in conventional immunoblotting with the phospho-specific antibody and 
total protein antibody. Second, the data provided by the Phos-tag method allows for more 
detailed mutational analysis, providing information on how individual phospho-species change 
in mutants of the protein of interest, or other proteins. For example, Phos-tag analysis of Fus3 in 
mutants lacking the upstream kinase Ste7, scaffolding protein Ste5, or phosphatase Msg5, 
revealed a mechanism of negative regulation attributed specifically to the mono-phosphorylated 
species of Fus3 [156]. Third, when used to analyze samples from a time course, the Phos-tag 
method allows kinetic tracking of each phospho-species, a feature that is lacking by many other 
methods, save for quantitative mass spectrometry, which may still give skewed results depending 
on the location of phosphorylation sites, and becomes very costly when used for time course 
analyses. Finally, quantitative measurement of phosphorylation over a range of stimulus 
concentrations and time has been extremely useful in developing mathematical models to 
represent the dynamics and regulation of signaling pathways [126, 156]. Such models can be 
used to predict the behavior of mutational or environmental perturbations to the pathway, and 
implemented as part of iterative, prediction-experimentation tests for understanding biological 
systems. Our previous Phos-tag analysis of Fus3 used this process to reveal a mechanism of 
negative regulation attributed specifically to the mono-phosphorylated species of Fus3 [156]. 
The major draw-back to the Phos-tag method is that some proteins simply give poor 
separation of phospho-species. Individual phospho-species from larger, and/or more-heavily 
phosphorylated proteins are more difficult to separate by the Phos-tag method, and may result in 
a band smear that changes position with the phosphorylation state, as with the yeast Ste11 
MAPKKK adaptor protein, Ste50. While Ste50 is slightly smaller than a MAPK, it possesses 
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five phosphorylation sites, and migrates as a quantifiable smear through a Phos-tag gel [126]. 
Scrupulous optimization of gel conditions specific for Ste50 may yield better separation of 
individual phospho-species, and the necessity for protein-specific optimization is one factor to 
consider when deciding to use the Phos-tag method. Another consideration is the availability of 
antibodies specific for the protein of interest. If no such antibody is available, it is possible to use 
a tagged version of the target protein. Tag size will affect the electrophoretic mobility of the 
protein, and small epitope tags should be favored to maximize the separation potential. With 
optimized conditions, the Phos-tag method is clearly ideal for the analysis of MAPKs and other 
small proteins with few potential phosphorylation states, and future advances may make possible 
the analysis of larger, more highly phosphorylated proteins. 
Transcriptional activity reporter assays 
Activation of Fus3 and Kss1 leads to phosphorylation of the transcription factor Ste12, 
which induces a number of genes required for mating. Among the most strongly induced genes is 
FUS1, which is also highly specific to the pheromone response [63]. Accordingly, the FUS1 
promoter is widely used as a reporter of pathway activation [64, 150]. The FUS1 promoter has 
been fused to reporter genes that encode β-galactosidase and fluorescent proteins (e.g., GFP), as 
well as drug resistance and nutritional markers. 
The β-galactosidase transcriptional reporter assay using the PFUS1-LacZ construct has 
been the gold standard. An increase in β-galactosidase expression can be detected by cleavage of 
a suitable substrate. Colorimetric reagents such as ONPG required cell lysis and are no longer 
widely used, having been replaced by the cell permeable substrate FDG [150]. As shown in 
Figure 3.5A, after exposure to pheromone for 1.5 hours, wild-type cells reach a maximum 
response at ~30 μM, with an EC50 of ~1 μM. Cells lacking the α-factor protease Bar1, respond at 
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Figure 3.5  Pheromone-induced gene transcription assays  
Dose-response curves for transcriptional output in response to α-factor mating pheromone. After 
1.5 hours of pheromone stimulation of wild-type and bar1Δ cells, similar results are obtained by 
(A) the PFUS1-LacZ and (B) the PFUS1-GFP reporter. Increasing the incubation time in the PFUS1-
GFP reporter system increases the maximum response in (C) wild-type cells and (D) bar1Δ cells, 
without changing the EC50. Data are presented as mean ± standard deviation, N = 4.  
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10-fold lower concentrations of pheromone. Similar results are observed using an alternative 
construct where the FUS1 promoter drives expression of GFP (Figure 3.5B). A notable 
difference between the two assays is that the PFUS1-GFP assay exhibits higher basal signaling in 
both the wild-type and bar1Δ strain. This difference is likely due to a lower relative fold change 
in fluorescence in the PFUS1-GFP assay. 
As shown in Figure 3.5C and D, with longer incubation time, the maximum GFP signal 
continues to increase, reaching approximately four times the maximum signal observed at 1.5 
hours. Notably, the EC50 does not change appreciably over time in either the wild-type or the 
bar1Δ strain. As the maximal signal increases over time, the fold increase in fluorescence 
relative to basal signal also increases. At 1.5 hours, the GFP signal over basal is ~10-fold. At 3 
hours this increases to ~15-fold. Overall, this is lower than the increase in fluorescence obtained 
in a PFUS1-LacZ assay; at 1.5 hours, the fluorescence increase over basal is ~25-fold. Therefore, 
PFUS1-LacZ has a higher signal to noise range than PFUS1-GFP. This sensitivity is the primary 
advantage of the PFUS1-LacZ assay. Another advantage is that β-galactosidase does not have as 
long of a maturation time as GFP. Indeed, GFP takes, on average, 60 minutes to fully mature in 
vitro [162, 163]. Reading the PFUS1-GFP assay at the same time point as the PFUS1-LacZ assay, is 
therefore observing the transcriptional activity slightly in the past.  
The PFUS1-GFP assay does possess several advantages, however. One advantage of using 
PFUS1-GFP is that multiple time points can be measured in the same experiment. One can simply 
measure the OD600 and fluorescence, continue incubating the plate, and measure again as often as 
is desired. To do a comparable experiment using the PFUS1-LacZ approach, one plate per time 
point is required, since the growth conditions and cell integrity are compromised by the addition 
of the fluorescent substrate solution. As the fluorescent substrate is relatively expensive, time 
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course experiments by PFUS1-LacZ can quickly become costly. Another advantage to using the 
PFUS1-GFP system is that cell membrane integrity remains intact throughout the experiment. This 
becomes important, for example, in studying conditions of environmental stress. Certain 
stressors, such as changes in pH, can alter the activity of the β-galactosidase enzyme upon cell 
permeabilization, thereby altering the amount of fluorescent product produced. Intact cells are 
efficient in maintaining a physiological pH, and a GFP-based assay will give a more accurate 
fluorescent signal.  
 
Conclusions 
Here, we have reviewed two methods for measuring MAPK phosphorylation and two 
measures of transcriptional induction in pheromone-treated cells. We illustrated the utility of 
each method by comparing the activity of wild-type and bar1Δ mutant strains.  
Based on our experience, we consider the Phos-tag SDS-PAGE and immunoblotting 
method to be superior to conventional immunoblotting with phospho-specific antibodies. Phos-
tag permits the separation of all three phospho-species of MAPKs—dually phosphorylated, 
mono-phosphorylated, and non-phosphorylated. Ratiometric quantification of these phospho-
species throughout a time course offers phospho-dynamics information that can be used to better 
understand the regulatory mechanisms at play in signal transduction pathways. This information 
is more informative than that obtained by conventional immunoblotting because phospho-
specific MAPK antibodies do not distinguish between the two phosphorylated species. Still, 
immunoblotting with phospho-specific antibodies is convenient, and can provide information 
about the relative sensitivity of various mutants to pheromone.  
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We also compared two methods for monitoring the transcriptional activity of the 
pheromone response pathway—the β-galactosidase-based PFUS1-LacZ assay and the fluorescent 
protein-based PFUS1-GFP assay. We found that both assays are able to provide comparable 
results, and each assay has its advantages. The β-galactosidase-based assay has higher sensitivity 
(i.e., higher fold change in signal) than the GFP-based assay, and is advantageous when a higher 
dynamic range is required. The GFP-based assay is more economical, can be easily monitored 
over time, and is less susceptible to conditions that interfere with enzyme activity. 
The methods described herein are applicable not only to the yeast system, but to MAPK 
pathways in other organisms. The assays can be adapted to monitor other signaling systems for 
biological characterization or drug discovery. 
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CHAPTER 4 – GENERAL DISCUSSION AND CONCLUSIONS 
 
In situations of life or death, decisions must be made to favor survival. In a cell, the 
decision to respond to environmental insults, such as osmotic stress, outweigh the decision to 
procreate. Here, we have uncovered a new piece of the puzzle that is the cross-pathway 
coordination of the environmental stress response with pheromone response signaling in yeast. 
We identified 2-hydroxy BCAA derivatives as metabolites that serve as second messengers to 
inhibit the mating response during osmotic stress (Figure 4.1). As second messengers, these 
molecules are likely used to amplify the signal of osmotic stress so that necessary cellular 
resources are diverted toward responding to the stress and away from reproductive functions. We 
determined that Hog1 is required for the production of these second messengers, and that Gpa1 is 
phosphorylated by Elm1 as a consequence of their production. However, we were unable to 
identify the molecular target of these new second messengers. Further experiments in yeast to 
determine the target molecule(s) that interact with these second messengers, as well as the 
mechanism by which Hog1 promotes their production will be key in fully understanding this new 
stress-response axis, as well as in identifying potential new target molecules for pharmacological 
control of the stress response in a mammalian system. 
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Figure 4.1  Model of BCAA derivatives as second messengers for osmotic stress. 
In our model, hyperosmotic stress serves as the first messenger stimulus that activates the 
osmosensors of the HOG pathway, Sln1 and Sho1. Receptor activation then leads to activation of 
the effector, Hog1. Hog1 then increases production of the BCAA derivative second messengers 
by an as yet unknown mechanism. These second messengers then promote the phosphorylation 
of Gpa1 and the adaptive response of mating pathway signal dampening. 
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Future Directions  
Determine the molecular target of the BCAA derivative second messengers  
We have demonstrated that BCAA derivatives promote phosphorylation of Gpa1, so it is 
likely that they target some component of the G protein signaling complex (i.e., Gα, Gβγ, the 
GPCR, RGS protein, the kinase, or the phosphatase). We have ruled out the Gα subunit by 15N-
1
H 2D NMR (Figure 2.7), one of the most conclusive tests for protein-ligand binding. We have 
also determined that the kinase responsible for phosphorylating Gpa1during osmotic stress is the 
AMPKK Elm1(Figure 2.8).  
 If Elm1 were the target of the BCAA derivatives, we would expect to see less 
transcriptional dampening in response to osmotic stress or ectopic addition of BCAA derivatives 
in cells lacking Elm1. However, ablation of any Gpa1 phosphorylation by deletion of all three 
AMPKKs did not result in any substantial increase in the maximum response to mating 
pheromone and KCl or mating pheromone and BCAA derivatives. At lower concentrations of 
pheromone, the response was higher in cells lacking AMPKKs compared to wild-type cells, 
consistent with reduced Gpa1phosphorylation. At intermediate concentrations of pheromone, 
KCl still dampened transcription, but BCAA derivatives had comparatively little effect alter the 
response to BCAA derivatives (Figure 2.10). These results are largely inconclusive insofar as 
implicating Elm1 as the target for BCAA derivatives. Further studies using purified Elm1 are 
necessary to identify it as the target, or rule it out. 
Expression of Elm1 that was codon-optimized for E. coli resulted in high protein yield, 
but this protein was largely in the insoluble fraction of the lysate. Purification from the insoluble 
fraction is possible, but may not yield active protein. Further optimization of this purification 
process and validation of protein activity by in vitro kinase assays for Elm1 autophosphorylation 
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would be needed before experiments to identify Elm1 as the BCAA derivative target can be 
carried out. Alternatively, Elm1 can be purified from yeast. The GST-tagged library contains 
GST-Elm1 under control of the inducible GAL1 promoter [164]. Elm1 is a relatively low-
abundance protein in yeast [54, 165], so inducible expression in this system will allow for higher 
protein yield. The GST epitope tag will allow for easy protein purification as done previously 
[83]. 
Once purified, Elm1 interaction with BCAA derivatives could be tested for in a number 
of ways. The hypothesis is that binding of BCAA derivatives to Elm1 would promote better 
kinase activity. One way to test this is to assay for increased Elm1 autophosphorylation in the 
presence of BCAA derivatives compared to that observed in the absence of BCAA derivatives, 
using the kinase-dead Elm1
K117R
 mutant as a negative control. A more rigorous test of direct 
binding of BCAA derivatives to Elm1 would be fast quantitative cysteine reactivity (fQCR) 
[166].  This approach uses increasing temperature to expose cysteine residues protected within 
the protein to bulk solvent.  Solvent exposure enables these cysteine residues to then be labeled 
with the fluorescent thiol compound. The relative change in protein conformation can then be 
monitored over a range of temperatures by measuring the fluorescence. The midpoint of thermal 
unfolding (Tm) is then calculated and compared between treated and untreated protein samples. 
Elm1 possesses 14 cysteine residues in its primary structure, so would be a protein amenable to 
this approach. Alternatively, isothermal titration calorimetry (ITC) could be employed, and 
would allow for determination of specific binding constants. 
Other components of the G protein complex could be assayed for interaction with BCAA 
derivatives much in the same way as described for Elm1 above. Purification of Ste4/Ste18 (Gβγ) 
[167] and Sst2 (RGS) [168] is possible. It should be noted, however, that proper controls must be 
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used to account for the acidic nature of the BCAA derivatives. Optimization of buffering 
conditions is necessary to be sure that any effects observed are specific to the BCAA derivativs, 
and not due to decreased pH. 
Once the target of the BCAA derivatives is identified, further mechanistic studies can be 
carried out to identify how the second messenger-target interaction promotes Gpa1 
phosphorylation and/or reduced MAPK pathway activation. Potential mechanisms include 
increased phosphorylation by increased kinase activity of Elm1 (discussed above), and decreased 
MAPK activation through increased affinity for the RGS and increased affinity for Gβγ, as both 
of these mechanisms would promote the “off” state of the pathway. With purified Gpa1, Sst2, 
and Ste4/Ste18, surface plasmon resonance (SPR) experiments could be conducted in the 
presence and absence of BCAA derivatives to assess changes in binding affinities between Gpa1 
and Ste4/Ste18, Gpa1 and Sst2, or even all three components together. Elucidation of the 
molecular target of the BCAA derivatives will provide information necessary for the 
development of new potential therapeutic strategies in managing the detrimental aspects of the 
response to cell stress. 
Determine the mechanism by which Hog1 promotes BCAA derivative production 
Our metabolomics study shows that Hog1 is required for the dramatic increase in BCAA 
derivatives observed upon osmotic stress. However, we have so far been unable to find a specific 
role for Hog1 in promoting BCAA catabolism. We attempted to identify a role for Hog1 in 
phosphorylating the branched-chain amino acid transaminase enzymes, Bat1 and Bat2, by 
mutating potential MAPK consensus phosphorylation sites to the non-phosphorylatable residue 
alanine, and using Phos-tag SDS-PAGE and immunoblotting to detect changes in 
phosphorylation between the mutants and wild-type cells in the presence or absence of osmotic 
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stress. We found no significant difference in the phosphorylation profiles of the Bat1 and Bat2 
mutants compared to the wild-type versions upon KCl stimulation (Figure 2.5). Likewise, we 
saw no clear change in the abundance of either Bat1 or Bat2 upon KCl stimulation. As Bat1 and 
Bat2 regulate the first step in BCAA catabolism (Figure 2.4A), it seemed that those enzymes 
would be the most logical target for regulation by phosphorylation by Hog1. As this was not the 
case, it may be prudent to widen the scope of potential mechanisms that might account for Hog1-
dependent production of BCAA derivatives. 
Our metabolomics analysis compared wild-type and Hog1-deficient cells. Therefore, it is 
unclear whether Hog1 catalytic activity or the binding of Hog1 to other proteins is required for 
the production of BCAA derivatives. Indeed, catalytically inactive MAPKs can still bind to and 
regulate transcription factors [169, 170]. To determine how Hog1 contributes to BCAA 
derivative production, first it should be determined whether Hog1 binding or kinase activity 
drives production of BCAA derivatives. To this end, targeted metabolite analysis by mass 
spectrometry or NMR could be employed to measure BCAA derivatives in a pharmacologically 
inhibitable (‘ATP-analog-sensitive’) Hog1 mutant (Hog1T100A), a Hog1-deficient mutant 
(hog1Δ), and wild type cells in the presence and absence of osmotic stress. If Hog1 catalytic 
activity is required for increased BCAA catabolism, then upon osmotic stress, a decrease in 
BCAA derivatives in the Hog1
T100A
 samples as compared to wild type, and similar levels as 
compared to hog1Δ samples should be observed. If Hog1 binding, and not catalytic activity is 
required, then upon osmotic stress, BCAA derivative levels in the Hog1
T100A
 samples should be 
similar to that observed in wild-type cells, and increased as compared to hog1Δ samples. 
Next, to identify proteins that interact with Hog1 upon osmotic stress, the bacterial biotin 
ligase BirA can be fused to Hog1. Subsequent biotinylation of proximal proteins upon osmotic 
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stress can be detected by mass spectrometry. Hog1 interaction studies have been done in the past, 
but not using this method. An advantage to the BirA approach is that it can capture transient 
interactions that can be missed in other assays, such as co-immunoprecipitation. This may reveal 
new Hog1-interacting proteins, some of which may be involved in BCAA catabolism. 
Another possible mechanism by which Hog1 could promote BCAA derivative production 
is through transcriptional regulation of BCAA catabolic enzymes. We have shown that Bat1 and 
Bat2 levels do not change in response to osmotic stress (Figure 2.5). However, other components 
of the Ehrlich pathway or alternative oxidoreductase enzymes may be transcriptionally regulated 
by Hog1. Indeed, several genes are upregulated on the same short time scale in which we 
observe increased BCAA derivative production and Gpa1 phospohrylation. A meta-analysis of 
an in-depth microarray analysis of wild-type and hog1Δ cells subjected to osmotic stress for 
various amounts of time [171] reveals that there are 40 genes whose expression is increased 
greater than 2-fold by 20 minutes after osmotic stress in wild-type cells, but not in hog1Δ cells 
(Figure 4.2). Of these 40 genes, 8 are oxidoreductases (ALD2, TKL2, ALD4, YML131W, ARI1, 
THI4, GRX7, and GRX1), and Ald2 and Ald4 are involved in the Ehrlich pathway. It is possible 
that one or more of these genes is responsible for producing the BCAA derivative second 
messengers. To follow up on this analysis, protein levels should be measured by western 
blotting. Subsequently, a direct role of these proteins in BCAA derivative production can be 
confirmed by deletion of the gene of interest, followed by measuring BCAA derivative levels by 
targeted metabolomics as described above. Determining the mechanism by which Hog1 
upregulates BCAA catabolism in response to osmotic stress will likely be translatable to stress-
response MAPK systems in humans. 
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Figure 4.2  Osmotic stress-dependent, Hog1-dependent gene transcription. 
Meta-analysis of microarray data [171] reveals that 40 genes increase at least 2-fold by 20 
minutes in response to osmotic stress by 0.5 M KCl in wild-type cells, but not in hog1Δ cells. 
Similar expression changes were observed upon osmotic stress by a comparable 1 M sorbitol 
stimulation. Mating pheromone (α-F) was used as a negative control. 
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Broader applications of this research 
Molecules generated from amino acid metabolism are some of the most common 
signaling agents in physiological systems. Serotonin, the neurotransmitter responsible for good 
mood and well-being, is derived from tryptophan. Dopamine, norepinephrine, epinephrine are 
derived from tyrosine. Dopamine is responsible for reward-associated behavior and motor 
control, and norepinephrine and epinephrine control the autonomic nervous system. Glutamate 
acts as an excitatory neurotransmitter, and its derivative, gamma-aminobutyric acid (GABA) is 
the principle inhibitory neurotransmitter. Interestingly, all of the aforementioned amino acid 
derivatives are ligands for GPCRs, emphasizing the interconnectedness of amino acid 
metabolism and G protein signaling. Next, I will discuss how BCAAs and their derivatives can 
also behave as signaling molecules in cell growth, and their potential as therapeutics. 
BCAAs as signaling molecules 
The most prominently up-regulated BCAA metabolite in our metabolomics analysis was 
the 2-hyroxy carboxylic acid derivative of leucine (HIC). HIC was also found to be the most 
bioactive of the three BCAA derivatives. This is consistent with the known role of leucine as a 
signaling molecule. Leucine promotes cell growth through protein synthesis and mitochondrial 
biogenesis [172]. Amino acids, particularly leucine, stimulate growth signaling through the 
mTOR pathway by promoting the active state of Rag-family small GTPases [173, 174], which 
then bind to Raptor, recruiting the mTORC1 complex to endomembrane compartments 
containing the activator, Rheb [173]. In yeast, the Exit from G0 Complex (EGOC), containing the 
Rag GTPase ortholog, Gtr1, is positively regulated in leucine-rich conditions by leucyl-tRNA 
synthetase, increasing TORC1 activity [175]. Conversely, EGOC is negatively regulated by the 
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Seh1-associated (SEA) complex (GATOR in mammals) through increased GTP hydrolysis 
activity of Gtr1 under leucine-starvation conditions, which decreases TORC1 activity [176].  
While much is known about the role of leucine as a signaling molecule in normal growth 
and in disease states, there is no real consensus on whether leucine or, more broadly, BCAA 
supplementation as a whole is beneficial or detrimental to overall health [177]. Indeed, 
performance athletes frequently make use of BCAA supplementation to promote muscle growth 
and recovery, and to prevent delayed-onset muscle soreness [178, 179]. Other studies show that 
high levels of circulating BCAAs in combination with a high-fat diet can promote insulin 
insensitivity and diabetes [74, 180]. Further, tissue-specific differences in BCAA metabolism 
exist among different cancers. Two Kras-driven cancers, pancreatic ductal adenocarcinoma 
(PDAC) and non-small cell lung carcinoma (NSCLC), exhibit opposing preferences in utilizing 
BCAAs for tumor growth; BCAA uptake is largely unchanged in PDAC compared to normal 
pancreatic cells, whereas NSCLC displays enhanced BCAA uptake compared to normal lung 
cells [181]. To add further to this complexity, BCAA supplementation has been shown to 
improve chemotherapeutic efficacy in inhibiting hepatocellular cancer stem cell growth [182, 
183]. Clearly, there is still much to be learned to fully understand the extent to which BCAAs 
and their metabolites act to regulate the growth and meet the energy demands of cells. 
BCAA metabolites as signaling molecules 
It is becoming more apparent that BCAA metabolites play equally, or even more, 
important roles in cells as the BCAAs themselves. Indeed, 2-ketoisocaproate (KIC), the product 
of leucine transamination, can promote TORC1 activity as effectively as leucine in both yeast 
and skeletal muscle [102, 184]. Interestingly, this effect is specific to leucine and KIC in yeast, 
as the other BCAAs, valine and isoleucine, and their keto acid metabolites, 2-ketoisovalerate, 
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and 2-keto-3-methylvalerate, respectively, do not promote TORC1 activity [102]. These findings 
are in line with our results that the 2-hydroxy derivative leucine, HIC exhibits the greatest 
increase in abundance and ability to dampen pheromone signaling.  
2-hydroxy acids are tolerated for use as dietary supplements, and can indeed promote 
growth. The analogs of each BCAA, 2-keto acid, and 2-hydroxy acid were tested for their ability 
to increase body mass in rats and chicks, and it was found that the L-isoforms of each 2-keto acid 
and 2-hydroxy acid similarly promoted growth in both species, albeit to a lesser capacity than 
that of the L-BCAA [185]. However, there do appear to be specific functions for 2-hydroxy 
acids. Compared to leucine, administration of HIC during and after the immobilization period of 
limb casting in rats was shown to improve atrophied muscle recovery upon cast removal [186]. 
In in soccer athletes, HIC supplementation for 4 weeks led to increased lean body mass and 
reduced delayed-onset muscle soreness after intense exercise compared to placebo groups [187]. 
Clearly, BCAA derivatives confer a clinical significance, yet remain poorly understood overall. 
We have identified a new function for 2-hydroxy BCAA derivatives, and the identification of 
their mechanism of action could serve to identify new therapeutic targets and applications. 
Potential application of BCAA derivatives to stress-related cell damage: ischemia-
reperfusion injury as an example 
Cardiovascular disease (CVD) is the most prevalent cause of death in the United States. 
Of the 85.6 million Americans affected by CVD, an estimated 7.6 million have suffered 
myocardial infarction (MI) [188]. Ischemia resulting from MI induces cell stress and damage due 
to poor nutrient delivery, and timely coronary reperfusion is the only proven way to limit infarct 
size. Paradoxically, reperfusion of ischemic tissue is known to cause rapid cell damage and death 
by both apoptosis and necrosis, termed lethal ischemia-reperfusion injury (IRI) [189-192]. The 
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extent to which IRI occurs has a significant impact on the survival of the affected individual. 
Therefore, limiting cell damage and retaining myocardial function has been the objective of 
many studies dedicated to understanding the molecular mechanisms by which IRI occurs [192-
196]. Factors found to contribute to the severity of IRI include generation of reactive oxygen 
species, induction of inflammatory responses, and fluxes in pH and osmolarity [191, 194]. 
Activation of AMPK, and the MAPKs, JNK and p38, by these conditions permits an adaptive 
response leading to cardioprotection [39, 40, 80, 196, 197]. Furthermore, signaling through 
GPCRs promotes stress adaptation and cardioprotection by suppressing apoptosis through Akt 
and MAPK signaling [4, 195]. 
Our work here considers the effects of 2-hydroxy acids on mediating the response to 
osmotic stress. Given the known activation of Hog1 in osmotic and oxidative stress, it is 
probable that these 2-hydroxy acids are also produced in response to those stresses in mammals 
through p38 or JNK signaling, and future experiments should aim to determine if this is true. If 
so, 2-hydroxy acids could be used as protective therapeutics during ischemia and ischemia-
reperfusion injury following myocardial or cerebrovascular infarction. Indeed, 2-keto acids 
derived from BCAAs were found to inhibit necrosis induced by the oxidative stress associated 
with IRI [198]. Similarly, studies aimed at identifying changes in myocardial metabolism in 
infarcted and failing mouse hearts did detect the valine-derived 2-hydroxy acid (HIV) in mice 
that underwent trans-aortic constriction (TAC) to induce heart failure, or coronary ligation to 
induce MI. HIV showed a nominal increase in experimental, but not sham mice after 8 weeks of 
TAC, as well as after 5 days of induced MI [76]. However, metabolites were not measured 
directly following MI to study the early events following ischemia, nor was a model of ischemia-
reperfusion injury explored where blood flow was restored after MI. Additional experiments in 
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this area should be conducted to determine the extent to which BCAA derivatives might play a 
role in mediating the stress response in the heart or brain. 
 
Concluding remarks 
As we search for a more complete understanding of how cells receive and respond to 
signals in their environment, we continue to find new connections between signaling pathways. 
It is clear that these pathways are not isolated systems, and are instead part of interwoven 
networks that, amazingly, maintain the fidelity necessary to execute the appropriate response to a 
given signal. In this dissertation, I have identified a new component of the network that responds 
to osmotic stress, whereby BCAA catabolism produces second messengers to reduce signaling 
for cell reproduction and to permit stress adaptation. Deregulated cross-talk between network 
components can lead to disease. Therefore, it is important that the mechanisms by which this 
new BCAA catabolism component acts are identified and the potential for 2-hydroxy BCAA 
derivatives as drug lead compounds is explored.  
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